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Eukaryotic cells are characterised by membranes with varied and dynamic compositions
and shapes. Consequently, membrane-binding proteins are tuned to recognise and modify
these membrane states to perform their functions. To study the curvature sensitivity of
proteins, I have developed a single-particle assay using NanoSight technology that tracks
the Brownian motion of particles to measure their size. I optimised this system to track
fluorescently labelled lipid-binding domains bound to liposomes of different sizes moving
freely in solution. The comparison of the size distribution of the total liposomes with the
fluorescently labelled population allowed me to determine their curvature preferences. To
validate the method I tested proteins from the Bin/Amphiphysin/Rvs (BAR) superfamily,
which are inherently curved and have known curvature preferences. My method was capa-
ble of recapitulating the behaviour of BAR domains with different curvature preferences.
I then expanded the range of targets and showed that this assay is also capable of detect-
ing curvature preferences for a variety of other lipid-binding domain families. As such, I
identified AKT PH domain as a new curvature-sensing domain. Finally, using the ENTH
domain of Epsin1 that causes vesicle budding, I demonstrated that this method can also
be used to study membrane remodelling.
Trafficking involves generation and sensing of membrane curvature combined with recogni-
tion of specific cargo. Endophilin consists of a curvature-sensitive BAR domain followed by
an SH3 (Src-homology 3) domain and has recently been identified in a clathrin-independent
endocytosis pathway, FEME (fast endophilin-mediated endocytosis), involved in the up-
take of cell surface receptors. Endophilin recognises ligands via its SH3 domain, binding
G-protein coupled receptors (GPCRs) directly in their intracellular loop 3 and receptor
tyrosine kinase (RTKs) via adaptor proteins. However, a specific recognition motif has
not been identified yet. Here, using a combination of biophysical approaches and NMR
spectroscopy, I characterised the Endophilin binding motif of ALIX (ALG-2-interacting
protein X) adaptor protein and of the GPCR α2A adrenergic receptor. Comparison of
SH3-peptide models resulted in a putative Endophilin recognition site.
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Chapter 1
Introduction
1.1 Membrane curvature
1.1.1 Membrane shape
Eukaryotic cells are characterized by membranes with varied and dynamic compositions
and topologies. Specialised cells like neurons or enterocytes (intestinal epithelial cells) have
a highly defined and regulated shape in form of dendritic trees or microvilli. More generally,
even in less specialised cells, the plasma membrane can harbour particular highly curved
structures such as filopodia. In all eukaryotic cells, intracellular membrane compartments
have a shape adapted to their function. Although some organelles, like lysosomes and
peroxisomes can be spherical, other organelles display different shapes (Fig. 1.1A). The en-
doplasmic reticulum (ER) forms a network of interconnected tubes and sheets (Fig. 1.1B),
the Golgi consists of stacks of perforated membranes (Fig. 1.1C) while mitochondria form
a tubular system (Fig. 1.1D). Even within organelles, membranes can take a specialised
shape, for example cristae of the inner mitochondrial membrane (Fig. 1.1E) or intercon-
nected thylakoid stacks in chloroplasts.
Although some of those structures are stable over time, most are highly dynamic, being
remodelled not only during cell division, growth or migration but also at steady state,
as in trafficking. Changes can occur locally, by bending or extending a tube from a flat
membrane (Fig. 1.1F). Alternatively, more profound changes can modify the topology of
membranes. Topological remodelling occurs through membrane fusion and fission, for
example fusion between ER tubules creating three-way junctions.
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Figure 1.1: Membrane curvature in cellular structures.
A. Cell. B. ER tubes and sheets. C. Perforated Golgi membranes. D. Mitochondrial
tubular network. E. Mitochondria inner structure. F. Tube extending from endosome.
A, C, E were taken from [1], B from [2], D from [3], F from [4] and were reproduced with
permission.
1.1.2 Generation of high membrane curvature
Formation and remodelling of membrane structures requires changes in membrane cur-
vature. Positive curvature corresponds to convex structures and negative curvature to
concave structures (Fig. 1.2).
Figure 1.2: Curvature topology on an endocytic vesicle.
Several mechanisms have been described for generation of high membrane curvature (Fig. 1.3)
[4, 2, 5]. Curvature can either be generated by processes intrinsic to the membrane and be
mediated by lipids or integral or peripheral membrane proteins or curvature can be applied
by cytosolic proteins binding transiently to membranes without insertion.
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Figure 1.3: Mechanisms of cellular curvature generation.
A. Lipid asymmetry: lipid accumulation on one leaflet (left) or non-cylindrical lipids
(right). B. Conical transmembrane proteins (top left), transmembrane proteins with large
non-membrane domains (top right), hairpin membrane insertion (bottom left), clustering
of transmembrane proteins (bottom right). C. Shallow insertion in one leaflet. D. Pro-
tein crowding. E. Cytoskeleton pushing (left) or pulling via molecular motors (right). F.
Oligomerisation of flat monomers (left) into helical structures around (middle) or inside
(right) the constriction. G. Crescent-shape protein dimers with positive (left) or negative
(right) curvature. H. Indirect scaffolding. Adapted from [4, 6, 7]
Membrane-intrinsic mechanisms
The first mechanism is driven by asymmetry between the two membrane leaflets (Fig. 1.3A).
One possible source of lipid asymmetry comes from the action of flippases that transport
lipids between leaflets [8, 9]. Accumulating lipids in one leaflet over the other can drive
membrane bending (Fig. 1.3A, left). For example, given a 5 nm membrane thickness, a
50 nm vesicle would contain 56% more lipids on the outer than the inner leaflet [4].
The relative volumes of headgroup and acyl chain of each lipid also influence their curvature
generating properties. Cylindrical lipids with similar sizes of headgroups and acyl chains
like phosphatidylcholine (PC) can form stable planar bilayers [10]. On the other hand,
lipids with headgroups smaller than their acyl chains like phosphatidylethanolamine (PE)
or phosphatidic acid (PA) favour negative curvature while lipids with opposite properties,
larger headgroup than acyl chain like lysophosphatidic acid (LPA), prefer positive curva-
ture. An alteration of membrane curvature can therefore occur by changing lipid properties,
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modifying the size of the lipid headgroup using enzymes [11], like interconverting LPA and
PA using phospholipase A2 or lysophosphatidic acid acyl transferase [12, 13, 14] (Fig. 1.3A,
right).
Besides the distribution and composition of lipids, curvature can also be achieved by full
or partial insertion of protein into the membrane. Curvature can be imposed by conical-
shaped integral membrane proteins or transmembrane proteins with large non-membrane
domains (Fig. 1.3B, top left and right). For example, the transmembrane region of nicotinic
acetylcholine receptors or voltage dependent K+ channels is conical [15, 16] and these re-
ceptors accumulate in areas of higher membrane curvature [17, 18]. To efficiently generate
high local curvature (30-50 nm diameter) at physiological concentrations, integral mem-
brane proteins would need to have a highly conical shape, seldom achieved except in rare
cases for proteins with hairpin insertions in the membrane like caveolins [19] (Fig. 1.3B,
bottom left). Alternatively, clustering of transmembrane receptors via attachment proteins
would also further increase local membrane curvature [20, 21] (Fig. 1.3B, bottom right).
Shallow protein insertions in only one leaflet, down to the interface between headgroup and
acyl chain, will push headgroups apart and consequently wedge the surrounding acyl chains
apart (Fig. 1.3C) [22]. An accumulation of such insertions in close proximity will generate
membrane curvature. This has been calculated and experimentally measured for several
amphipathic helix-containing proteins such as α-synuclein [23], ENTH (Epsin N-terminal
homology domain) [24, 25] or N-BAR (N-terminal helix and Bin/Amphiphysin/Rvs) do-
main proteins like Endophilin [26, 27]. Insertion of hydrophobic loops or segments can also
generate membrane curvature, as seen with the tandem C2 domains of Synaptotagmin1
[28, 29] or with reticulons and DP1/Yop1 family proteins [30]
More recently, a new mechanism has been proposed, where collisions between membrane-
tethered proteins generates sufficient lateral pressure to bend the membrane [31] (Fig. 1.3D).
In this case, close proximity of membrane-tethered proteins is necessary and sufficient to in-
duce membrane curvature, without need of insertion into membranes. The authors showed
that in their in vitro system, a protein coverage above 20% was sufficient to bend mem-
branes and targeting to the membrane could be achieved either by insertion of a helix
into the membrane or by binding specific lipid headgroups. For example, targeting enough
His-GFP to giant unilamellar vesicles (GUV) containing Ni-bound lipids (Ni-NTA-DOGS)
was sufficient to generate tubules. Pushing this hypothesis further, the same group showed
that intrinsically disordered proteins, when targeted to membranes, were powerful curva-
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ture generators, as they occupy a larger hydrodynamic volume than a globular protein of
similar molecular weight, as shown for the C-terminal domains of Epsin and AP180 [32].
Membrane-extrinsic mechanisms
Membrane curvature can also be generated by forces imposed by the cytoskeleton and
molecular motors or by the interaction, without insertion, of cytosolic proteins with the
membrane. Polymerisation of the cytoskeleton itself can generate membrane curvature
(Fig. 1.3E, left), for example, actin filaments are involved in the formation of filopodia,
pseudopodia, phagocytic cups and axonal growth cones [33, 34, 35, 36]. Moreover, the
cytoskeleton can also generate stable curved membrane regions through motor proteins
(Fig. 1.3E, right). During the cytokinesis step of cell division, actin rings form at the
membrane between the two future daughter cells. Contraction of the rings by the action of
myosin II forms a furrow where later on, membrane fusion will occur to separate the two
daughter cells [37]. Pulling membranes along microtubules, connected through proteins
of the kinesin and dynein family [38] can extend tubules. This has been implicated in
formation of the ER tubular network [39, 40].
Peripheral membrane proteins can deform membranes by forming a curved scaffold around
them. This can take several forms. Polymerisation of straight monomers into helical
oligomers can drive membrane curvature generation (Fig. 1.3F, left). Oligomerisation can
occur around the necks of the membrane being constricted, as is the case for dynamin
at the neck of endocytic vesicles [41, 42, 43] (Fig. 1.3F, middle). Alternatively, proteins
oligomerising inside the constriction, as is the case for ESCRTs (endosomal sorting com-
plexes required for transport) [44], mediate budding away from the cytoplasm, inside multi-
vesicular bodies [45, 46, 47] or towards the extracellular space for virus budding [48, 49, 50]
as well as cytokinesis [51, 52, 53] (Fig. 1.3F, right).
Crescent-shape protein dimers can also provide scaffolding sufficient to bend membranes
(Fig. 1.3G). Bin/Amphiphysin/Rvs (BAR) domains are typical examples for this category
of protein and define a superfamily of proteins [54]. BAR domains are elongated helical
domains with various inherent curvatures, ranging from very positive (BAR and N-BAR
like Arfaptin, Endophilin, Amphiphysin) (Fig. 1.3G, left), shallow positive (F-BAR like
FCHo2) to negative or inverted (I-BAR like IRSp53) [55, 56, 57] (Fig. 1.3G, right). Addi-
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tion of those proteins onto artificial membranes generates tubules, as seen for example with
Arfaptin2 [58] and FCHo2 [56], or tubules with inverted geometry with IRSp53 [59, 60].
In the two previous examples of scaffolding generating membrane curvature, the curved
protein oligomers or dimers bound directly to the membrane. However, curved coats
can also generate membrane curvature by binding indirectly, via adaptor proteins, to the
membrane (Fig. 1.3H). This is the case for clathrin, COPI and COPII protein coats [61, 62].
Clathrin itself has no affinity for membranes , however other proteins like Epsin, CALM
(clathrin assembly lymphoid myeloid leukemia) or amphiphysin bridge it to the membrane.
It is worth noting, that in a majority of cases, more than one mechanism is involved in
generating curvature. For example N-BAR domains like the one of Endophilin or Am-
phiphysin consist of both an amphipathic helix and a BAR domain [26, 58]. Both the H0
amphipathic helix of Endophilin as well as the BAR domain were shown to be involved in
generating membrane curvature [63, 27], although the importance of H0 for curvature gen-
eration has been contested [64]. In addition, Endophilin and other BAR-domain proteins
have also been shown to form striations on membrane tubules [65], so oligomerisation might
be an additional force for curvature generation. Epsin was shown to curve membranes both
through insertion of its N-terminal amphipathic helix [24] and a crowding effect enhanced
by its intrinsically disordered C-terminal region [32], although H0 insertion was shown to
contribute more than crowding [5].
1.1.3 Sensing membrane curvature
To maintain cellular homeostasis, biochemical reactions need to happen at the right place at
the right time. The diverse shapes of membranes present in a cell offer, in addition to lipid
composition, an additional mechanism to spatiotemporally control reactions happening at
cellular membranes. For example, during clathrin-mediated endocytosis, as formation of
the bud into a vesicle progresses, different curvatures are generated and are indicative of
how far clathrin-mediated endocytosis has progressed. This could fine-tune the timing of
protein recruitment for curvature-sensitive proteins.
Two main mechanisms by which proteins can sense membrane curvature have been de-
scribed (Fig. 1.4) [58, 66, 67, 68, 6]. One of the mechanisms relies on scaffolding. There,
a curved, positively charged, protein surface will preferentially bind a negatively charged
membrane surface of corresponding curvature, as this would maximise interaction energy.
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Figure 1.4: Mechanisms of cellular curvature sensing.
A. Scaffolding by crescent-shape proteins. B. Scaffolding by oligomers of flat monomers.
C. Hydrophobic insertions in lipid packing defects. D. Folding of amphipathic helix onto
curved membrane. Adapted from [66]
Crescent-shaped BAR domains, in addition to their curvature generation activities de-
scribed above, can also preferentially bind membranes of similar curvature as has been
shown for Endophilin BAR binding on highly curved liposomes [26] or MTSSL1 (metasta-
sis suppressor 1 like) I-BAR on negatively curved membranes [69] (Fig. 1.4A).
Curvature sensing by scaffolds can also happen for proteins forming curved oligomers
(Fig. 1.4B). For example, at low concentrations, Dynamin helices assemble on the neck
of vesicles, an area of high curvature [70, 71]. In the gram-positive bacteria B. subtilis,
DivIVA oligomers specifically localise to areas of the cell with negative curvature, cell poles
and polar septum during cell division [72, 73, 74].
Curved protein scaffolds can sense various curvatures ranging from very high positive
curvatures to negative curvatures. An alternative mechanism, specific for highly curved
membrane surfaces, consists of asymmetric hydrophobic insertions (Fig. 1.4C). Curved
membranes formed of cylindrical lipids or substantial amounts of conical lipids or lipids with
mono-unsaturated acyl chains in flat membranes generate lipid packing defects [75, 76].
Lipid packing defects result from a geometrical mismatch between lipid and membrane
shape [75] and correspond to areas of lower lipid density.
Typical motifs for curvature sensing using hydrophobic insertions are amphipathic helices.
Amphipathic helices are disordered in solution but fold into a helix when in contact with
membranes (Fig. 1.4D) [24, 77, 26]. They lie flat, parallel to the membrane at the depth
of the phosphate-glycerol backbone [26, 78, 79, 80]. A well studied example of curvature-
sensing amphipathic helices are ALPS (amphipathic lipid packing sensors) found in several
proteins of the early secretory pathway, for example the nucleoporin Nup133, the sterol-
binding protein Kes1p, the golgin GMAP-120 [81] or ArfGAP1 (ADP-ribosylation factor
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GTPase-activating protein 1) [82]. ArfGAP1 activation of GTP hydrolysis by Arf1 is
essential for COPI coat disassembly [83, 84, 85]. This process should however only happen
once the vesicle is fully formed and mature. A good indicator of vesicle maturation is its
shape and therefore curvature. ArfGAP1 affinity for membranes [86] and resulting activity
increase dramatically for small vesicles (smaller than 100 nm diameter) [82], a size similar
to that of typical coated vesicles. During coat assembly and vesicle maturation, Arf1-GTP
is protected from hydrolysis as the affinity of ArfGAP1 for flat membranes is weak. Once
the vesicle reaches a critical size, ArfGAP1 is recruited via its ALPS motif, triggering
GTP hydrolysis and coat disassembly. This is an elegant way to spatiotemporally control
a biochemical process.
The amphipathic helix formed by ALPS has a hydrophilic face with few charged residues,
mostly serines and threonines [77, 81, 87, 88] and a hydrophobic face with large hydropho-
bic residues [86]. Other curvature sensing amphipathic helices with different properties
have been described. The N-terminus amphipathic helix of α-Synuclein has large, charged
residues like lysines on its hydrophilic face and small hydrophobic amino acids as well as
threonines on its hydrophobic face [89, 90]. The B. subtilis protein SpoVM that binds to
the positively curved forespore has a central proline residue that introduces a kink in the
helix [91].
A common feature of curvature-sensing amphipathic helices is their unusual properties
compared with other amphipathic helices [67]. The absence of charged residues on the hy-
drophilic face of ALPS and its insensitivity to the presence of charged lipids suggest that
binding is driven by hydrophobic interactions. Interestingly, introducing charged amino
acids on the hydrophilic face of ALPS increases its affinity but decreases its curvature
sensing ability by increasing its affinity for flat membranes [81]. Introducing hydropho-
bic residues on the hydrophobic face of α-Synuclein increases its affinity but reduces its
curvature sensitivity [92]. This suggests a mechanism by which hydrophobic insertions
contribution to curvature sensing must exceed affinity for flat membranes provided by
electrostatics [92].
Hydrophobic insertions not related to amphipathic helices can also provide curvature sen-
sitivity. Synaptotagmin1 C2 domains [28] or a cyclic peptide derived from loop 3 of Synap-
totagmin1 C2B domain [93] preferentially bind small liposomes. Alkyl chains attached to
proteins as in the geranylgeranylated Gβ1γ2 or a C16-chain covalently attached to ovalbu-
min can also act as curvature sensors [94]. Curvature sensing can also be observed in the
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accumulation of conical transmembrane proteins like cytochrome b5 [95] or GPCRs [96] in
regions of higher membrane curvature.
More than one curvature sensing module can be present as is the case for N-BAR domains
[68, 97, 60] although one study argues that only the amphipathic helix is responsible for
curvature sensing [98] as N-BAR, F-BAR and I-BAR proteins tested all preferentially
bound to small liposomes. N-BAR contain a typical amphipathic helix, but presence of
amphipathic helices has also been reported in other BAR and I-BAR proteins [97, 60, 98]. A
different way of combining curvature sensing modules was found in the lipid kinase Vps34/
PIK3C3 (Phosphatidylinositol 3-kinase catalytic subunit type 3). This protein can form
multiple complexes with a three-dimensional Y-shaped structure [99]. Complex I formed
of Vps34, Vps15, Vps30 and Atg14 is active in autophagy and complex II, where Atg14 is
replaced by Vps38, is important in endocytic sorting. Whereas complex II was active both
on Giant Unilamellar Vesicles (GUVs), and Small Unilamellar Vesicles (SUVs), complex
I activity was restricted to SUVs. Both complexes bind lipids through the Vps34 kinase
located at the tip of one of the arms of the Y, however complex I also has an ALPS-like
amphipathic helix in the BATS domain of Atg14 (absent in complex II, replaced by Vps38)
situated at the tip of the other arm of the Y. This shape might accommodate smaller
liposomes better than flat membranes. A combination of ALPS and three-dimensional
structure of a protein complex might explain the specific activity for complex I on SUVs
only.
Finally, it is worth noting that several proteins can act both to sense curvature as well as
generate tubules or vesicles (Endophilin N-BAR [26], FCHo2 F-BAR [58], I-BAR [59, 100]).
Dynamin is both a curvature sensor at low concentration [70, 71] and a generator at
high concentration [101]. Curvature sensing and generation might be two faces of the
same principle where protein concentration, affinity for membranes and protein/lipid ratio
dictate which phenomenon dominates.
1.2 Lipid-binding domains
1.2.1 BAR domains as curvature sensors and generators
BAR domains were first identified as a conserved domain in Bin/Amphiphysin/Rvs [102,
65, 58] and are involved in membrane binding, curvature sensing or generation. Crystal
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structures for several BAR domains have been solved and show a conserved architecture of
three kinked helices forming a coiled coil. BAR domains exist as weak dimers in solution
[58, 26, 56], although subnanomolar affinity for Endophilin dimers has also been reported
[103]. Upon dimerisation, BAR domains form a six-helix bundle with a curved positively
charged surface (Fig. 1.5). This crescent-shaped surface binds negatively charged mem-
branes. Several classes of BAR domains were identified based on the curvature or the
dimer, ranging from very concave (classical BAR), shallow concave (F-BAR) to convex (I-
BAR) (Fig. 1.5, top). Additional features like amphipathic helices (N-BAR) or additional
lipid-binding domains (Pleckstrin homology PH in BAR-PH or Phox homology PX in PX-
BAR) were also identified in some members of the BAR domain superfamily (Fig. 1.5,
bottom).
Figure 1.5: BAR domains overview.
BAR domains can sense membrane curvature by preferentially binding to liposomes of a
specific diameter range [58, 26, 69]. They have also been shown to induce tubulation or
vesiculation [58, 26]. The rigidity of the BAR domain is essential for curvature generation
as no tubulation was observed in an Endophilin mutant with increased flexibility in the
arms of the BAR domain [104]. N-BAR domains present an unstructured N-terminus
that folds into an amphipathic helix, called H0, upon membrane binding [26]. Presence
of an additional amphipathic helix with a large positively-charged hydrophilic face and
a large hydrophobic face in N-BAR domains confers additional affinity for membranes
[58, 65, 105] by lowering the koff [65] in membrane binding. In vitro, the H0 helix is not
necessary for vesiculation by Endophilin or Amphiphysin [58, 64] and tubulation was still
present in H0 deletion mutants albeit at higher protein concentrations. However, increasing
the number of amphipathic helices per BAR domain was shown to favour vesiculation over
tubulation and to generate vesicles of smaller sizes [106]. After deletion of H0, BAR
curvature sensitivity increased as seen for Endophilin [26] and Amphiphysin [58], although
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a different assay shows that curvature sensitivity is entirely mediated by the amphipathic
helix [98].
F-BAR domains are characterised by a shallower concave membrane-interaction surface
(Fig. 1.5). Addition of F-BAR on liposomes induced tubulation. The size of tubules
varied from 20 to 70 nm diameter for FCHo2 depending on the protein concentration [107].
In the case of Cip4, tubules were larger and with a more homogeneous diameter of 60-
80 nm [108]. Tubules induced by overexpression of F-BAR in mammalian cells had a
larger diameter than tubules resulting from overexpression of N-BAR proteins [108]. This
supports a mechanism of curvature generation based on scaffolding. Ordered protein arrays
on lipid tubules have been observed for several F-BAR proteins [107, 109, 110] and cryo-EM
studies on FBP17 (Formin-binding protein 17) showed the importance of both tip-to-tip
interactions as well as lateral contacts for formation and stabilisation of a helical structure
[108].
Unlike other BAR domains, I-BAR form a convex surface and have been shown to bind
[100, 69] and stabilise negative membrane curvature in vitro as well as in vivo [59]. Over-
expression of IRSp53 I-BAR induced extracellular instead of intracellular tubules (as ob-
served for N- and F-BAR) [111] and addition of the same construct on lipid vesicles induced
invaginations towards the inside of the liposome [59].
Several BAR domain proteins also contain an additional lipid-binding domain, Pleckstrin
homology (PH) or Phox homology (PX), both specific for phosphoinositides. Combin-
ing a curvature-sensing module (BAR) with a phosphoinositide-specific one (PH or PX)
would provide coincidence detection not only for a membrane compartment of given lipid
composition but also for particular microdomains with a specific curvature [112]. Sortin
Nexin 1 (SNX1) is formed of a PI(3)P/PI(3,5)P2 specific PX domain followed by a high
curvature specific BAR domain. Functionality of both domains was required for correct
targeting of SNX1 to tubular structures of the early endosome and for working endosome
to trans-Golgi network trafficking [112]. Coincidence detection might also occur for BAR-
PH domain although this is less understood: in APPL1, the PH residues usually involved
in phosphoinositide binding are not conserved [113] although the PH domain still binds
phosphoinositides [114].
With their functions of membrane curvature sensing and generation, BAR domains are
especially useful in trafficking processes. During clathrin-mediated endocytosis, shallow
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curved FCHo1/2 proteins are recruited at early stages and were proposed to sculpt the ini-
tial bud site [107, 115]. At later stages, N-BAR domains with higher curvatures, Endophilin
and Amphiphysin, are recruited to clathrin-coated pits with Dynamin [116] and cooper-
ate with Dynamin in vesicle scission [116, 117]. BAR domain proteins have also been
involved in clathrin-independent endocytosis. The BAR-PH containing protein GRAF1
(GTPase Regulator Associated with Focal Adhesion Kinase 1) remodels membrane in the
tubulovesicular CLathrin-Independent Carriers and GPI-Enriched Endocytic Compart-
ments (CLIC/GEEC) endocytosis pathway [118] involved in internalisation of bacterial
toxins, GPI-anchored proteins and extracellular fluid. Endophilin is also involved in up-
take of Shiga and Cholera toxins in a clathrin-independent pathway [119]. Recently, our
group described a novel Endophilin dependent endocytic pathway called Fast Endophilin
Mediated Endocytosis (FEME). This pathway is responsible for ligand-triggered uptake
of G-Protein Coupled Receptors (GPCRs) and Receptor Tyrosine Kinase (RTKs) at the
leading edge [120] and the uptake of Cholera and Shiga toxins [119]. In this pathway,
Endophilin can bind cargo receptors through its C-terminal SH3 domain, induce mem-
brane curvature through its BAR domain and facilitate membrane fission with its multiple
amphipathic helices [106] in collaboration with Dynamin [116].
Other processes also make use of the BAR domains properties on membranes. Transverse
tubules (T-tubules) are narrow tubes extended from the plasma membrane in skeletal and
cardiac muscles [121] involved in muscle contraction. Their formation is dependent on
BAR domain proteins. In Drosophila melanogaster with mutations in Amphiphysin, the
T-tubule network is severely disorganized and the flies are flightless [122]. In mammals,
missense mutations in the BAR domain of Amphiphysin2 disrupting tubulation in cells
cause autosomal recessive centronuclear myopathy [123]. Similarly, initiation of the for-
mation of dendritic spines, post-synaptic protrusions of excitatory synapses, is reliant on
the I-BAR protein MIM/MTSS1 (Missing In Metastasis/Metastasis Suppressor protein
1) [124]. MIM binds PIPs-rich membranes [59] and deforms the membrane into proto-
protrusions prior to Arp2/3-complex actin polymerisation [124]. A similar phenomenon
was observed for WAVE-associated Rac GAP/slit-robo GAP 3 (WRP/srGAP3), an inverse
F-BAR (IF-BAR) domain protein (F-BAR with properties similar to I-BAR in terms of
convex shape and induction of "inverse" tubules). srGAP3 forms on dendrites a bud where
spine precursors emerge and deletion of srGAP3 resulted in impaired long-term memory
in mice [125].
12
1.2.2 Non-BAR lipid-binding domains
Figure 1.6: Structure of phospholipids. A. General structure. B. Common lipid head-
groups.
Recruitment of proteins on membranes is essential for processes as diverse as maintaining
cell and organelle shape, trafficking or signalling. Cellular membranes are composed of
several thousands different phospholipids and other lipids. The main phospholipid head-
groups are phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylser-
ine (PS), phospatidic acid (PA) and phosphatidylinositol (PI) (Fig. 1.6) [126]. In ad-
dition, lipids with different backbones (non phospholipids), sterols or sphingolipids, are
also present. The lipid composition varies between membranes of different organelles and
presence of specific lipid headgroups, especially differentially phosphorylated PI (PIPs)
marks specific membrane compartments [127]. Recognition of specific lipid headgroups
or of membrane properties (like charge) is essential for correct targeting and function of
peripheral membrane proteins. Several lipid binding domains with varied lipid specificity
have evolved (Fig. 1.7). Phosphoinositides can be specifically recognised by domains like
PH [128, 129], PTB [130, 131], GRAM [132], FERM [133, 134], PX [135, 136, 137, 138],
FYVE [139, 140, 141], PHD [142, 143], PROPPIN [144], PDZ [145], ENTH [24, 146],
ANTH [147, 148], whereas some are specific for DAG (C1 [149]) or PS and negatively
charged membranes (C2 [150], annexin [151], Gla [152], Discoidin C2 [153]).
Pleckstrin Homology (PH) domain was first identified in the N-terminus of pleckstrin and
was shown to bind PI(4,5)P2 [128]. A crystal structure of PLCδ-PH in complex with
IP(3,4,5)P3, the headgroup of PI(4,5)P2, identified the phosphoinositide binding site [154]
as a pocket formed by the β1-β2 loop with sequence motif KXn (K/R)XR (Fig. 1.7A)
[155]. Some PH domains, (Bruton's tyrosine kinase BTK [156, 157], General Receptor
for Phosphoinositides 1 GRP1 [158], Protein Kinase B PKB/AKT [159]) are very spe-
13
cific for the second messengers PI(3,4,5)P3 or PI(3,4)P2 produced after activation of cell
surface receptors and PI3K [160]. The high selectivity and affinity of these PH domains
allows specific targeting to membranes containing PI(3,4,5)P3 or PI(3,4)P2, despite the
higher concentration of PI(4,5)P2 [161]. Although some PH domains have high affinity for
phosphoinositides, genome-wide studies in yeast showed that most do not bind phospho-
inositides strongly [162].
Phosphotyrosine binding (PTB) domains specifically bind peptides with phosphorylated
tyrosines [130]. Though uncommon, some PTB domains interact with PIPs [163, 164, 165].
PTB are structurally similar to PH domains, the main difference being the presence of a
helix between β1 and β2 strands, a feature of PTB domains. One side of this helix forms
the PIPs binding site [163] (Fig. 1.7B). GRAM (Glucosyltransferases, Rab-like GTPase
activators and Myotubularins) domains also share a similar three-dimensional structure
with PH domains [166] and are specific for PI(3)P and PI(3,5)P2 [132] (Fig. 1.7C). FERM
(4.1, ezrin/radixin/moesin) domains are found at the N-terminus of proteins that link the
actin cytoskeleton to the plasma membrane. FERM domain consists of three subdomains
and its subdomain C also has a PH/PTB fold [167] and binds PIPs. The PIPs binding site
is however not in the PH/PTB fold but in a cleft between the additional C-terminal α-helix
of subdomain C and subdomain A [167] (Fig. 1.7D). FAK (Focal Adhesion Kinase) is kept
in an autoinhibited state by the FERM domains binding its catalytic domain [168, 169].
In a model of FAK activation by lipids, after formation of focal adhesions and activation
of PI4P5KIγ lipid kinase, high local concentrations of PI(4,5)P2 are synthesized and bind
in the FERM domain, releasing autoinhibition [170].
Phox Homology PX domains were first identified in p40phox and p47phox subunits of NADPH
oxidase complex [180]. Most PX domains are specific for PI(3)P [181] although some have
preferences for other PIPs [182, 183, 184] but only few bind with high affinity [181]. The
PX domain structure consists of three β-strands followed by four α-helices [182, 172]. The
PIPs binding pocket is formed by β1-β2 loop and one of the helices (Fig. 1.7E). p47phox has
an additional binding pocket for phosphatidic acid that contributes to membrane binding
[182].
FYVE (Fab1, YOTB, Vac1, EEA1) domains are zinc-finger domains specific for PI(3)P and
are thus mostly found in endosomal, multivesicular body and phagosomal proteins [185].
A shallow PI(3)P binding pocket is formed by conserved basic residues on β1 and provides
almost all hydrogen bonds to PI(3)P (Fig. 1.7F) [185, 173]. In addition, hydrophobic
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Figure 1.7: Overview of non-BAR lipid binding domains.
A. PH (1MAI) [154]. B. PTB (1M7E) [164]. C. GRAM (1ZVR) [171]. D. FERM (1GC6)
[167]. E. PX (1H6H) [172]. F. FYVE (1JOC) [173]. G. PHD (2G6Q) [174]. H. PROPPIN
(4AV9) [175]. I. PDZ (2PKU) [176]. J. ANTH (1HFA) [148]. K. ENTH (1H0A) [24]. L.
C1 (1PTR) [177]. M. C2 (1DSY) [178]. N. Annexin (1A8A) [179]. O. Gla (1NL2) [152].
P. Discoidin C2 (1CZS) [153]. The membrane-binding sites face down. Co-crystallised
lipids or lipid headgroups are shown in sticks. Grey spheres represent Zn2+ ions and yellow
spheres Ca2+ ions.
Adapted from [159]
residues in a loop penetrate in the bilayer [140]. FYVE domains are only efficiently targeted
to endosomes as dimers, increasing the avidity by binding two PI(3)P molecules [186, 173]
and EEA1 (Endosome Antigen 1) indeed includes a coiled-coil that allows dimerisation
of the FYVE domain (Fig. 1.7F) [173]. A structurally related zinc-finger domain, Plant
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Homeodomain PHD, present in several chromatin regulatory factors, has also been shown
to bind PIPs in the nucleus and regulate activity of ING2 (inhibitor of growth protein 2)
tumor suppressor (Fig. 1.7G) [142]. This has however been contested in a study showing
that a polybasic region C-terminal of the PHD domain and not the PHD domain itself is
responsible for PIPs binding and specificity [143].
PROPPIN (β-propellers that bind polyphosphoinositides) form a family of proteins in-
volved in autophagy that bind PI(3)P and PI(3,5)P2 with high affinity and selectivity
[175, 187, 188]. PROPPIN form a seven-bladed β-propeller with two PIPs binding sites
formed by charged and polar residues as well as each one of the arginines of the conserved
FRRG loop (Fig. 1.7H), that was previously shown to be essential for membrane binding
[144, 189]. Further affinity for membranes is provided by insertion of a hydrophobic loop
[187, 190]. Phosphorylation of this loop following environmental stress abolishes membrane
binding and promotes vacuole fusion in P. pastoris yeast [191].
PDZ (Postsynaptic density protein 95, Drosophila discs large tumor suppressor and zonula
occludens-1) domains are commonly found in multi-domain scaffolding proteins and gen-
erally bind to the C-terminus of binding partners by augmentation of one β-sheet [192].
Several PDZ domains, up to 20% according to large-scale studies [193], have been found to
bind PIPs and membranes through a cationic patch opposite the PDZ binding groove and
a cysteine-rich loop in the case of PICK1 (Protein Interacting with C Kinase 1) (Fig. 1.7I)
[176].
The N-terminal domains of several clathrin adaptor proteins, AP2 α-subunit [194], AP180
[147], CALM [148] (both have an AP180 N-terminal homology domain ANTH) and Epsin
(Epsin N-terminal homology domain ENTH) [24] share a superhelical solenoid fold (Fig. 1.7J,
K) and bind PIPs, mostly PI(4,5)P2. ANTH interacts with PI(4,5)P2 headgroup via a ba-
sic patch with low affinity (Fig. 1.7J) [194, 148], whereas the binding site on ENTH lies in
a pocket formed in part by H0, the unstructured N-terminus that folds into a amphipathic
helix upon membrane binding (Fig. 1.7K) and inserts into it, generating high curvature and
inducing vesiculation [24, 25]. Although ENTH of Epsin, a protein active on the plasma
membrane, preferentially binds PI(4,5)P2, ENTH domains found in other proteins can
have different lipid specificities. The ENTH domain of EpsinR, active at the trans-Golgi
network, is specific for PI(4)P instead [195, 196].
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C1 and C2 domains were named after the first and second conserved regions of protein
kinase C (PKC). The C1 domain binds diacylglycerol (DAG) and thus is responsible for
PKC activation [149], whereas the C2 domain provides calcium-dependent binding to PS
[150]. C1 domain is a cysteine-rich zinc-finger domain formed of two β-sheets followed by an
α-helix (Fig. 1.7L). C1 domains affinity for membranes comes from several mechanisms.
DAG or its analogue phorbol ester bind in a cavity between the β-sheets [177] forming
a hydrophobic surface that inserts into membranes [197, 198]. This brings a positively
charged surface in contact with acidic lipid headgroups [199], providing additional non-
specific electrostatic interaction.
C2 domains consist of eight β-strands organised in two four-stranded β-sheets (Fig. 1.7M)
[200]. Calcium ions bind in loops through acidic residues, inverting the electrostatics of
this region, thereby allowing binding to negatively charged lipid headgroups [201, 202].
Although C2 domains of conventional PKCs and Synaptotagmin bind PS, variations in
the calcium-binding loops generate diversity of phospholipid selectivity. For example the
C2 domain of cPLA2 binds zwitterionic PC instead [203, 204].
Conventional PKC isozymes (α, βI, βII, γ) contain both C1 and C2 domains and both are
necessary for high-affinity membrane binding and release of autoinhibition of PKC [205].
This suggests a model where cytosolic PKC C2 domain binds Ca2+, targeting PKC to
the membrane with low-affinity [206]. PKC then diffuses on the membrane until the C1
domain binds DAG, providing high-affinity binding and activation of PKC [205]. In novel
PKC (δ, , η, φ), the C2 domain does not bind calcium. Recruitment to membranes is
then mediated by the C1 domain only, which has a two orders of magnitude higher affinity
for membranes than conventional PKC C1 [207].
Several protein domains recognise PS via different mechanisms. Annexin core consists
of generally four α-helical annexin repeats that can each bind up to three calcium ions
through the loops linking the helices (Fig. 1.7N) [179]. Ca2+ ions are coordinated both by
protein residues and phospholipids, bridging annexin to the membrane. With the calcium-
dependence of membrane binding of most annexins, they have roles in diverse processes
involving calcium, including vesicle trafficking, intracellular signalling, membrane repair
and even display calcium-channel activities [208]. Gla (γ-carboxyglutamate-rich) domain
is found in extracellular proteins involved in blood coagulation [209]. Similar to annexin,
calcium ions are coordinated both by protein residues, in this case γ-carboxyglutamate,
and phosphatidylserine (Fig. 1.7O) [152]. Unlike annexins and Gla, discoidin C2 domains,
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structurally similar but unrelated to PKC C2 and found in coagulation proteins, bind PS
in the absence of calcium (Fig. 1.7P) [153]. Affinity for membranes and specificity for PS
are provided by a combination of insertion of hydrophobic loops, electrostatic interaction
between positively charged residues and phosphate groups as well as specific contacts to
the PS headgroup [153].
Spatiotemporal control of the recruitment of lipid-binding proteins to membranes is crucial
for cellular homeostasis. Correct localisation to a cellular compartment can be easily
achieved for lipid-binding domains with a strict requirement for the presence of a particular
lipid headgroup, for example FYVE domains are targeted to PI(3)P-containing endosomes
[185, 173]. Temporal control can be ensured in cases where synthesis of the preferred
headgroup is regulated as is the case for PI(3,4,5)P3-binding PH domains. Alternatively,
for calcium-dependent lipid-binding domains, recruitment to the membrane is controlled
by calcium influx into the cell. Since the discovery of lipid-binding domains, headgroup
specificity and calcium-dependency have been extensively studied [210, 159, 211], however,
except in a few isolated cases [28, 93, 212], little is known about curvature sensitivity of
non-BAR lipid-binding domains and how it contributes to subcellular targeting and protein
regulation.
1.3 Endocytosis and Endophilin
The plasma membrane delimits the boundary of the cell and organelles allow compartmen-
talisation of cellular processes, however regulated transport needs to occur across these
membranes and between intracellular compartments. Ions and small molecules can cross
membranes through proteic channels or transporters, but larger molecules, proteins and
lipids require transport via transient vesicles. Endocytosis is a process by which cells
take up essential nutrients, regulate cell-surface receptors and cell membrane area. It
is also an entry pathway for bacterial toxins and viruses. The best characterised path-
way is clathrin-mediated endocytosis (CME). During initiation of CME (Fig. 1.8A), lo-
calised membrane curvature is created, cargo is concentrated and scaffolding proteins
are recruited by the action of F-BAR domain containing proteins and adaptor proteins
[107, 213, 214, 215]. Clathrin is then recruited and assembles into a coat, while curvature
of the CCP (clathrin-coated pit) increases (Fig. 1.8B). After formation of a clathrin-coated
vesicle (CCV) (Fig. 1.8C), dynamin-induced scission releases the vesicle inside the cell
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(Fig. 1.8D) [216]. The vesicle is then uncoated, whereby clathrin is disassembled through
the action of heat shock cognate 70 (Hsc70) and either auxilin or cyclin G-associated
kinase (GAK) [217] and adaptor proteins are removed after hydrolysis of PI(4,5)P2 by
synaptojanin [218, 219].
Figure 1.8: Clathrin-mediated endocytosis stages.
A. Initiation of clathrin-coated pit (CCP). B. Maturation of CCP. C. Membrane teth-
ered clathrin-coated vesicle (CCV). D. Free CCV. (taken from [220] and reproduced with
permission)
Membrane curvature generation and sensing are essential for endocytosis. BAR domains
and amphipathic helices are two structural entities responsible for induction and recog-
nition of membrane curvature and N-BAR domain proteins possessing both are involved
in a variety of processes requiring membrane remodelling, one of these being endocytosis.
Endophilin contains, in addition to its N-BAR domain, an additional central amphipathic
helix (CAH), formed by a section of helix 1 (H1I) of the BAR domain (Fig. 1.9A). The
N-BAR domain is followed by a variable region containing several phosphorylation sites
[221, 222] and an SH3 (Src homology 3) domain mediating protein-protein interaction by
binding proline-rich sequences (Fig. 1.9B). Endophilin proteins form two subfamilies, A
and B, with similar overall structures, although H0 and the loop between helix 2 and 3
are longer in Endophilin B than A [223]. Endophilin A1, A2 and A3 are associated with
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processes on the plasma membrane whereas Endophilin B1 and B2 mostly act on intracel-
lular organelles [224, 225, 226]. Endophilin A2, B1 and B2 are expressed in most organs
whereas Endophilin A1 is the brain-specific isoform and Endophilin A3 is expressed both
in brain and testes [227, 228].
Figure 1.9: Structure of Endophilin N-BAR (A) and SH3 (B). A was modified from [26]
with permission, B is pdb 3IQL from [229]
CME is an important pathway for recycling of synaptic vesicles (SV) [230]. In neurons,
Endophilin A is localised at presynaptic nerve terminals and is recruited to presynaptic
membrane following synaptic stimulation [231, 232, 228, 233, 234, 235]. In the lamprey
giant synapse, interfering with the binding of Endophilin N-BAR to the membrane resulted
in accumulation of shallow CCPs at stimulated synapses, suggesting a role of Endophilin
N-BAR in CCP maturation [236]. Deletion of Endophilin A in flies and nematodes im-
paired SV endocytosis and caused an increase of both early and late-stage clathrin-coated
intermediates as well as free CCVs [237, 234, 232, 238], suggesting a role for Endophilin
at several stages of CME. Endophilin A also binds the PRD of both dynamin and synap-
tojanin via its SH3 domain [228] and forms a complex with dynamin on the narrow neck
of CCVs, which also promotes binding of dynamin to lipids in vitro [239]. Injection of a
peptide blocking Endophilin SH3 (PP19) [240] or antibodies against synaptojanin PRD in
the lamprey giant synapse both led to an accumulation of free CCVs [241] and Endophilin
was shown to be responsible for the correct recruitment and localisation of synaptojanin
during CME [218, 242] and therefore of vesicle uncoating [243]. Endophilin is also involved
in vesicle scission, as injection of Endophilin SH3 or PP19 peptide in the lamprey synapse
resulted in an accumulation of late-stage CCVs with a narrow neck [241].
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Although Endophilin plays an important role at different stages of SV recycling by CME,
increasing evidence shows its role in a clathrin-independent endocytosis (CIE) pathway.
In several synapses as diverse as inner hair cells [244], calyx of Held [245], hippocampal
boutons [246, 247] or ribbon synapse of retinal bipolar cells [248], different modes of endo-
cytosis differing by their speed were observed. At the goldfish retina ribbon synapse, after
a short stimulus, membrane retrieval occurred with a time constant of 1 s [249], whereas af-
ter longer stimuli, excess membrane was retrieved in two phases, where the fast mode was
followed by a slower endocytosis process (time constant 10 s). Disrupting amphiphysin-
dynamin interactions or clathrin binding to accessory proteins significantly reduced the
slow phase of endocytosis, whereas the fast phase was unaffected [248, 250] suggesting
that slow endocytosis relies on CME whereas fast endocytosis is clathrin-independent.
Blocking the fast phase could be achieved by introducing a dominant-negative Endophilin
construct lacking its SH3 domain resulting in a fraction of SV to be endocytosed by the
slow instead of the fast pathway [250, 251]. This indicated a role for Endophilin in fast,
clathrin-independent SV endocytosis.
In addition to its role in CME and CIE of synaptic vesicles, Endophilin is also involved in in-
ternalisation of activated receptors tyrosine kinase (RTKs) and G-protein coupled receptors
(GPCRs) using tubulovesicular carriers [120]. This clathrin-independent endocytic path-
way was named FEME (fast Endophilin-mediated endocytosis) [120]. After activation by
EGF (epidermal growth factor), EGF receptor (EGFR) is ubiquitinated by Cbl (Casitas B-
lineage lymphoma) [252], which recruits CIN85 adaptor (Cbl-interacting protein of 85 kDa)
[253]. CIN85 is constitutively bound to Endophilin through a PRD-SH3 interaction, linking
Cbl and Endophilin after EGF stimulation [254]. Using dominant-negative constructs to in-
terfere with CIN85 PRD  Endophilin SH3 complex formation reduced internalisation and
down-regulation of EGFR [254, 120], although the importance of Cbl-CIN85-Endophilin
for EGFR internalisation has been contested [255]. Cbl-CIN85-Endophilin was also im-
portant for internalisation of another RTK, the hepatocyte growth factor (HGF) receptor
Met [256, 120]. Alix (ALG-2 interacting protein X) is another adaptor protein that binds
Endophilin by PRD-SH3 contacts and is involved in Endophilin-dependent endocytosis
of EGFR [257]. Deletion of Alix delays EGFR degradation by lowering degradation rate
in the first hour after EGF stimulation, but the difference in degradation rate between
wild-type and knock-out cell lines disappeared in the following hours [257].
21
Unlike FEME uptake of RTK that proceeds through adaptor proteins linking RTKs to
Endophilin, Endophilin can bind GPCRs directly. In contrast to arrestin-mediated, CME
uptake of GPCRs where after receptor activation and phosphorylation, arrestin binds to
the C-terminal tail of the GPCR and interacts with AP2 and clathrin [258], Endophilin
binds proline-rich sequences in the intracellular loop 3 (ICL3) of some GPCRs with its SH3
domain [259, 120] mediating their uptake following ligand activation [120]. The structure
of Endophilin is well suited to its essential function in FEME. Its SH3 domain binds to
cargo and cargo adaptors and its N-BAR domain facilitates both formation of a vesicle
through scaffolding by the BAR domain and scission by inserting amphipathic helices in
the membrane [106]. In addition, Endophilin SH3 recruits dynamin [116], an essential
component for vesicle scission in FEME [120]. Endophilin has also recently been shown to
directly participate in scission of elongating tubules by imposing friction on the membrane
tube [260]. The FEME pathway can be highjacked by bacterial toxins [119]. Shiga toxin
induces tubular membrane invaginations as a first step for its uptake into cells [261], which
are recognised by Endophilin A2 [119]. Endophilin collaborates with dynamin and actin
for scission of vesicles from these tubular invaginations [119]. FEME was also reported
in axon growth cones, where Endophilin A3-mediated endocytosis of vesicles happens at
the apical side of the leading edge of the cone in a dynamin- and actin-dependent manner
[262].
The two members of the Endophilin B subfamily have been less studied than Endophilin
A, but show roles non-related to endocytosis. They mostly act on intracellular membranes.
The difference in localisation between Endophilin A and B is not well understood. H1I
plays a role as a chimeric Endophilin B1 construct with H1I from Endophilin A1 partly
redistributes to the plasma membrane [104]. However, localisation is more complex. Other
regions are also important as Endophilin A1 ∆H1I still localises to the plasma membrane
[104] and different lipid specificities, protein binding partners and potentially curvature
preferences probably contribute as well. Endophilin B2-deficient mice showed impaired
endosomal function and trafficking of vesicles to late endosomes and lysosomes [263]. En-
dophilin B2 also plays a role in mitophagy, in particular inner mitochondrial membrane
degradation together with Endophilin B1/Bif-1 [225]. Endophilin B1 was first identified
as a binding partner of BAX (Bcl2-associated X protein) [227, 264]. Bif-1 promotes the
conformational change of BAX [264, 265] necessary for its activation and subsequent perme-
abilisation of the mitochondrial outer membrane [266], which triggers caspase activation
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and apoptosis. Endophilin B1 is required to maintain the morphology of mitochondria
[267] and also plays a role in the generation of autophagosomes from Golgi membranes by
promoting formation of a Beclin1-UVRAG-PI3KC3 complex [268].
In addition to its roles in CME and CIE, Endophilin A is also involved in autophagy.
The Parkinson's disease associated kinase LRRK2 (Leucine-rich repeat kinase 2) phos-
phorylates Endophilin at position S75 (situated in H1I) [269]. Phosphorylated Endophilin
favours vesiculation over tubule formation when added on liposomes by preventing CAH
to insert deeply in the membrane [27]. The current model suggests a role for Endophilin
in autophagosome formation and maturation [270]. Endophilin, present on phagophore
membranes, generates high curvature, which helps recruit Atg3 [271], leading to lipidation
of Atg8 [272] and progression of autophagosome formation. In Endophilin A-deficient mice,
fewer autophagosomes, which could not be compensated by overexpression of Endophilin
B, were observed [273]. This reduced autophagic flux resulted in neurodegeneration [273].
1.4 Aims of this thesis
Membranes of eukaryotic cells occur in various shapes, flat areas, elongated tubules or
vesicles. Formation and sensing of membrane curvature by proteins is essential for cellu-
lar homeostasis. Two mechanisms by which proteins can sense membrane curvature have
been previously described [66]. The first relies on curved scaffolds that preferentially bind
to membranes of similar curvature [58], the second on amphipathic helices or hydrophobic
loops as sensors of lipid packing defects [77], a hallmark of highly curved membranes. How-
ever, several questions remain open. First, are there additional ways to sense membrane
curvature? To answer this, other lipid-binding domains should be screened for curvature
sensitivity and the mechanism by which they sense curvature studied. Second, there is
discrepancy over the relative contributions of BAR domains and amphipathic helices in
curvature sensing for proteins that contain both. Although initial experiments with BAR
domain proteins showed that the preferred vesicle size correlated with the shape of the
BAR domain, both in vitro and in vivo [26, 69, 59], newer data suggest that the amphi-
pathic helix only drives curvature sensing [94] and that flat F-BAR and negatively curved
I-BAR domains also preferentially bind to highly curved membranes. Using Endophilin as
a model, studying curvature sensitivity of constructs containing either only BAR or H0 as
well as mutants might shed light on this debate.
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To target both of these questions, an assay based on single particle should be used in
order to ensure accurate and precise sizing of the liposomes, to allow better discrimination
power than bulk assays. In addition, liposomes should be freely floating in solution to avoid
potential artefacts from surface tethering. As no current assay fulfils both requirements,
in this thesis I established a new method, NTA, based on sizing of freely diffusing particles
by their Brownian motion. After validating its sizing ability using calibration beads, I
could reproduce known curvature preferences of selected BAR domains. A screen of non-
BAR lipid-binding domains identified a new curvature sensor, the PH domain of AKT. I
also showed that NTA can be used to follow membrane remodelling, using vesiculation by
ENTH as a model system, opening the way to characterise other membrane remodelling
effectors.
Endophilin has been implicated at several steps of clathrin-mediated endocytosis [236, 237,
240, 243]. More recently, it has also been described as an essential component of a clathrin-
independent pathway, FEME, involved in uptake of activated GPCRs, RTKs [120] as well as
bacterial toxins [119]. Consisting of an N-BAR domain able to sense and generate curvature
as well as an SH3 domain recognising cargo and recruiting dynamin, Endophilin could be
involved in every step of the endocytosis process. However, apart from the receptors
identified by Boucrot et al. [120], little is known about the scope of FEME, which other
receptors transit through FEME or when FEME is used. Understanding cargo selection
by Endophilin SH3 would contribute to understanding of FEME, however existing data
based on peptide libraries and modelling were not enough to define a consensus Endophilin
binding motif. In this thesis, I characterised by NMR the binding of a cargo receptor and
an adaptor protein to Endophilin SH3 and generated models of the binding site. This
resulted in a putative consensus sequence that can be used to identify more FEME target
receptors.
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Chapter 2
Measuring curvature sensitivity of
proteins in a single-particle solution
assay
2.1 Introduction
Eukaryotic cells are characterised by membranes with varied and dynamic compositions and
topologies, ranging from elongated tubules and flat membrane areas to small vesicles. These
shapes are characterised by different local curvatures that have to be generated, maintained
and recognised by proteins. Shape of membranes is essential for their function, be it
trafficking, signalling, division or migration to cite only a few examples, and is necessary
to maintain cellular homeostasis.
Several methods have been developed to study curvature sensitivity of proteins. The
earliest developed assays are based on centrifugation [58]. There, the candidate protein is
incubated with liposomes of different sizes. Free protein and protein bound to liposomes
are then separated by centrifugation based on the different pelleting efficiency of liposomes
and proteins. Alternatively, presence of a fluorescently-tagged protein on a lipid surface,
either liposomes of different sizes, lipid tubes of variable diameter or a curved lipid film,
can be observed using microscopy [94, 274, 96, 275].
Two variations of the curvature sensitivity assay based on centrifugation have been de-
veloped. Both use liposomes extruded to different radii by passing through filters of set
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pore size [276]. In liposome co-sedimentation assays, the candidate protein is incubated
with liposomes that are then pelleted by ultracentrifugation. The ratio of protein in pel-
lets (with liposomes) or free in the supernatant for different sizes of liposomes indicates
curvature preference [58]. Alternatively, in a flotation assay, liposomes and proteins are
mixed at the bottom of a centrifuge tube and layered with a density gradient. During
ultracentrifugation, liposomes will rise to the surface due to their lower density. The ratio
of free protein at the bottom of the tube to protein bound to liposomes in the supernatant
indicates curvature preference [77].
Several methods relying on microscopy exist. In a single liposome curvature (SLiC) assay
[94], fluorescent liposomes containing biotinylated lipids are tethered to a streptavidin-
coated glass surface and their size is calculated from the fluorescent intensity after imaging
under a microscope. Imaging is repeated after addition of fluorescent protein to detect lipo-
somes to which protein bound. Another group used NTA (Nanoparticle Tracking Analysis)
to characterise curvature sensitivity of MARCKS-ED (the effector domain of myristoylated
alanine-rich C-kinase substrate) [277] and a cyclic peptide derived from Synaptotagmin1
[93]. NTA sizes freely diffusing particles by measuring their Brownian motion. Curvature
preference data can be obtained by comparing the size distribution of liposomes alone to
that of protein-bound liposomes.
An alternative way of generating curvature is by pulling a nanotube from a Giant Uni-
lamellar Vesicle (GUV) using a bead trapped in optical tweezers [274]. The GUV is aspi-
rated in a micropipette, whose suction force sets the membrane tension of the GUV. The
radius of the nanotube is determined by the aspiration force and the membrane bending
rigidity and can be adjusted by varying the suction force in the micropipette. Fluorescent
protein localisation on the tube and on the GUV can then be detected under a confocal
microscope.
The study of proteins binding to negative curvatures is difficult using liposomes which
display only positive curvatures. Solid-supported membranes are a useful tool [275]. In
this technique, a hard surface is engraved with a pattern, then a membrane bilayer, which
is expected to follow the patterning, is formed on top of the surface. Localisation of protein
on the crests or troughs of the wavy patterning can be observed under a microscope. A
similar assay has recently been used to study the effect of membrane curvature on clathrin-
mediated endocytosis [278].
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All methods described above measure curvature sensitivity in vitro using purified, fluo-
rescently labelled proteins. Curvature-driven protein localisation could also be observed
in vivo in the special case of B. subtilis [91, 73]. Bacteria generally lack intracellular
structures and cytosolic proteins only see mild negative membrane curvature. During for-
mation of the spore however, areas of positive curvature are generated around the spore
and some proteins like SpoVM have been shown to specifically localise to those regions
[91]. Preference for high negative curvature could also be observed for the protein DivIVA
that accumulates at poles and at the edge of the division septum in dividing B. subtilis
[72, 73]. In vivo curvature-dependent sorting of GPCRs (G-protein coupled receptors)
could also be assessed by measuring the distribution of GPCRs along filopodia or tubes
pulled from cell membrane [96]. Preference for high positive curvature was driven by the
conical shape of the transmembrane (TM) region of GPCRs. Redistribution of the GPCR
Y2R (neuropeptide Y receptor Y2) along filopodia also occurred after ligand activation,
which induces conformational changes in the TM domain [279].
All the existing methods have advantages and drawbacks (Tab. 2.1). Despite extrusion,
liposomes size distributions remain polydisperse [280] and even when using different filter
pore sizes, liposome size distributions are overlapping [98]. This results in lower discrim-
ination power for bulk techniques like liposome co-sedimentation or flotation assays. In
addition, in liposome co-sedimentation assays, artefacts due to protein pelleting, a result
of protein aggregation, multimerisation or simply use of large proteins, are common.
SLiC was developed to circumvent drawbacks arising from the polydispersity of sizes of
extruded liposomes by sizing particles individually. However, the tethering process might
introduce artefacts. As liposomes are tethered to a surface by a biotin-streptavidin link, but
are still in solution and therefore subject to Brownian motion, this may affect membrane
tension and increase hydrophobic defects, explaining why all domains tested with this
method tend to bind preferentially to higher curvatures, [94, 98] even those for which
dramatically different curvature preferences have been reported by other assays like for
I-BAR domain containing proteins [100].
Nanotubes pulled from GUVs can have various diameters, allowing the study of several
different curvatures sequentially [281, 282]. However, as the membrane is pulled into a
tube, the applied lateral tension affects lipid packing density and lipid diffusion [283]. This
might affect sorting of proteins on the membrane. Although solid-supported membranes
are especially useful to study negative curvature, the major drawback of this technique
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is that it relies on the assumption that the membrane closely follows the patterning of
the underlying surface. Confirming this or determination of the exact curvature is exper-
imentally hard. Studying curvature sensitivity in vivo may provide more physiologically
relevant information. It is however, for now, restricted to particular cases, like sporulation
or division in B. subtilis or sorting of integral membrane proteins [96].
Table 2.1: Comparison of existing methods to measure curvature sensitivity of proteins
Method Principle Advantages Disadvantages
Liposome different pelleting easy bulk, polydisperse liposome
co-sedimentation [58] efficiencies of free versus sizes, artefacts
liposome-bound protein from protein aggregation
Flotation assay [77] different densities of easy bulk, polydisperse
protein and liposomes liposome sizes
separated by a gradient
SLiC [94] localisation of fluorescent single-particle artefacts from
protein on liposomes sizing liposome tethering
tethered to a surface
Tubule from localisation of fluorescent set curvature application of
GUV [274] protein along tubules can be adjusted lateral tension
pulled from a GUV
Solid-supported localisation of fluorescent study of negative hard to determine
membrane [275] protein on membrane curvature precise membrane
layered on a curvy surface preference curvature
In vivo [91, 96] localisation of fluorescent physiologically limited to
protein on specialised relevant special cases
subcellular structures
In order to test membrane curvature sensing of proteins, I wanted a technique that combines
advantages of liposome co-sedimentation/flotation and SLiC assays while avoiding their
drawbacks. For this, a single-particle, solution technique would be ideal. There, liposomes
would be freely floating in solution avoiding potential artefacts from tethering to a surface.
In addition, a large population of liposomes would be sized individually, allowing better size
determination than in bulk assays. For these reasons, I turned to NanoSight Nanoparticle
Tracking Analysis (NTA) developed by Malvern. NTA is a microscopy-based technique
where freely diffusing liposomes can be individually sized based on their Brownian motion.
Experimental design to measure curvature sensitivity of proteins using NTA would involve
sizing all liposomes or protein-bound liposomes only. Comparing both size distributions
would indicate curvature preference of the protein tested.
NTA uses light diffraction to image particles moving freely in solution by Brownian motion.
Position in the x and y dimension of each particle is tracked over time and mean squared
displacement (x, y)
2
is calculated. For diffusion in two dimensions, generally (x, y)
2
=
4Dt. Although Brownian motion occurs in three dimensions, NTA records motion in two
dimensions, as a two-dimensional projection of a three-dimensional trajectory.
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The Stokes-Einstein equation (Eq. 2.1.1) describes how the diffusion coefficientD correlates
with the diameter d of a particle, temperature T and solvent viscosity η (t represents time
and KB Boltzmann constant).
Dt =
TKB
3piηd
(2.1.1)
By combining those two equations, the size d of a particle can be calculated with Eq. 2.1.2.
(x, y)
2
4
= Dt =
TKB
3piηd
→ d = TkB
3piηD
=
4TkB
3piη(x, y)
2 (2.1.2)
NTA can detect particles by recording diffracted light. Alternatively, insertion of a long-
pass filter blocks diffracted light and allows detection of fluorescent particles only. In order
to measure the curvature sensitivity of protein binding to membranes, unlabelled liposomes
can be detected by diffraction. After addition of fluorescently-labelled protein, only lipo-
somes with bound protein will appear fluorescent and those can be detected in fluorescence
mode. Alternatively, different dyes with different excitation/emission wavelengths could
be used to label liposomes and proteins.
In this thesis, I demonstrate the use of NTA to study curvature sensing and vesiculation.
I first validated NTA's sizing capability with calibration beads of known sizes. Where
curvature sensitivity of proteins was previously known, this was reproduced by NTA. Next,
other lipid-binding domains were screened for curvature sensitivity. Finally, curvature
generation was also monitored by NTA.
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2.2 Results
2.2.1 Nanoparticle tracking analysis using NanoSight technology
The instrument, NanoSight LM10 (Malvern), used in this study is based on a conventional
upright microscope (Fig. 2.1A). The sample is imaged in a specially-designed glass chamber
where the bottom surface, called optical flat, is coated with a metallised surface to reduce
background (Fig. 2.1B). The sample can be made to flow using a syringe pump to reduce
photobleaching and increase the number of particles tracked (Fig. 2.1C). Laser light is
used for illumination of the sample. As laser light reaches the layer of liquid sample after
passing through the glass optical flat, the light is refracted and forms a beam through the
sample (Fig. 2.1D). Particles present in the sample will diffract light that is then collected
by a long working distance 20x objective (Fig. 2.1E). In order to collect red-shifted light
emitted by fluorophores, a long-pass filter is introduced to block diffracted light (Fig. 2.1F).
Imaging acquisition and single particle tracking and analysis is performed using Nanosight
NTA software (Malvern).
The typical procedure I followed for data collection using NTA goes as follows. The samples
are prepared and diluted in NTA buffer as described in Material & Methods (chapter 5)
and then introduced into the imaging chamber using the syringe pump. 60-120 s movies
are recorded using a high-sensitivity CMOS camera operating at 25 frames per second.
After background subtraction, the centre of particles is determined (Fig. 2.2, red crosses).
The threshold for detection of particles can be adjusted depending on the intensity of
the particles present in the sample. Particles are then automatically tracked (Fig. 2.3A).
The top number next to each particle indicates the estimated size of that particle for the
last frame, while the bottom number indicates the number of frames that particle has
been tracked for. Three parameters are automatically set for each movie but can also be
adjusted manually [284]. "Blur" allows smoothing of pixel intensities around a particle to
reduce noise, e.g. from diffraction rings, thus reducing the number of false particle centres.
"Max jump distance" indicates the maximal distance from a particle in a given frame in
which it will look for this particle in the next frame. In order to prevent accidentally
merging tracks from different particles, if another particle enters the zone defined by the
max jump distance, tracks from both particles will be discarded from further analysis.
"Min track length" sets the minimum number of consecutive frames a particle has to be
tracked for, in order for it to be included in the analysis. Tracking over a larger number
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Figure 2.1: Working principle of NanoSight LM10.
A. Microscope. B. Glass optical flat with metallised surface. C. Syringe pump. D. Laser
beam going through sample. E Particles diffracting light. F Long-pass filter blocking
diffracted light and letting only fluorescence emitted light through. (A, C were reproduced
with permission from Malvern)
of frames increases the accuracy of size determination. It however reduces the number
of fast diffusing, small particles tracked as they might move out of the small observation
volume and biases the data towards larger, slower diffusing particles. While the data are
processed, plots of concentration (Fig. 2.3A) and intensity as a function of size (Fig. 2.3B)
as well as a three-dimensional plot combining the two previous plots (Fig. 2.3C) appear.
At the end of the tracking, for monodisperse samples like calibration beads, the data can be
further corrected by FTLA (finite track length adjusted). As the depth of scattering volume
is small, particles, especially small ones, are tracked for only a few frames, resulting in
artificial line broadening without affecting the mean. This can be mathematically modelled
and compensated for [285]. After application of FTLA correction, the true distribution can
be recovered. Further corrections for vibration and drift are then applied using a Malvern
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Figure 2.2: Detection of particle centres
Figure 2.3: Tracking of particles.
A. Tracking of single particles with individual sizes overlayed with plot of concentration as
a function of size. B. Intensity as a function of size. C. Concentration and intensity as a
function of size.
proprietary algorithm, resulting in the final data. Drift originating from pump flow is
subtracted by calculating the total drift of all particles (which should be zero in a static
sample as Brownian motion is random) and subtracting it from each particle's trajectory.
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The number of particles per size are binned in 5 nm bins. The concentration of particles in
each bin is calculated using the estimated dimensions of the observation volume (100µm by
80µm field of view by 10µm beam depth [286]). Data with the concentration of particles
in each bin can then be exported and used with a plotting software.
Data can be presented as plots of concentration as a function of size (Fig. 2.4A) like in
the direct output of the NTA software. Alternatively, data can be displayed as box plots
with the box containing 25-75% of the data and the middle line indicating the median.
Whiskers on each side show where 10-90% of the data is situated (Fig. 2.4B).
Figure 2.4: NTA data representation. A. Concentration versus size. B. Corresponding
box plot
The experimental design to measure curvature sensitivity of protein binding to membrane
consists of fluorescent lipid-binding domains being added to non-fluorescent liposomes.
Measurements using diffraction detect all liposomes and provide a size distribution for
the entire liposome population, whereas after introduction of the fluorescent filter, only
fluorescent liposomes are visualised, i.e. only liposomes which have fluorescent protein
bound. Comparison between size distributions obtained by diffraction and fluorescence
indicate the curvature preference for a given protein.
Concentrations of detected particles should be kept to 108-109 /ml (corresponding to pM)
[284]. This corresponds to 10-100nM lipids, assuming a liposome contains 10'000 to 100'000
lipid molecules. Using lower concentrations of sample reduces the statistical accuracy of the
size measurement. On the other hand, if the sample concentration is higher than 109 /ml,
particles tend not to get resolved from each other, as they are in too close proximity. In
addition, the probability of particles crossing path, resulting in both particles' tracks being
discarded, increases. Regarding fluorescent proteins, concentrations have to be kept below
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5 nM, otherwise background of unbound protein becomes too high. Measurements were
therefore generally conducted at 1-2 nM.
2.2.2 NTA validation
The first step undertaken was to check the precision and accuracy of NTA to size parti-
cles and compare it to the established Dynamic Light Scattering (DLS) method. For this,
calibration beads were used. The sizes were chosen to be similar to typical liposomes,
hence 100 nm and 216 nm. NTA sized these beads at 100±5 nm and 217±11 nm respec-
tively (Fig. 2.5). As liposome size distributions are broader than calibration beads, I then
wanted to test how NTA would size calibration beads when they were mixed. As shown
in Figure 2.5 (green curve), NTA was able to differentiate both populations of beads. I
then repeated the experiment using DLS. Size distributions obtained for individual beads
were broader than NTA, 110±10 nm and 214±22 nm (Fig. 2.6). In addition, DLS was not
able to distinguish both populations after both sizes of beads were mixed. Instead, the
size obtained, 180±60 nm, was intermediate between both populations. 100 and 216 nm
beads were too close in size to be discriminated by DLS. Therefore, NTA was more precise
and accurate than DLS and was also better at differentiating two populations of beads of
different sizes in a biologically relevant size range.
Figure 2.5: Size distribution of 100 nm and 216 nm calibration beads based on NTA
During measurements of curvature sensitivity, I would expect fluorescent proteins to bind
to only a sub-population of unlabelled liposomes, so the next control was to check NTA's
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Figure 2.6: Size distribution of 100 nm and 216 nm calibration beads based on DLS
ability to size fluorescent particles when mixed with unlabelled particles of a different size.
For that, I sized separately fluorescent liposomes extruded at 50 nm (Fig. 2.7, blue curve)
and 200 nm unlabelled liposomes (Fig. 2.7, black curve) using diffraction. Both populations
were then mixed and the size of fluorescent particles determined (Fig. 2.7, red curve). Size
distributions of fluorescent 50 nm liposomes measured on their own or in a mix of large,
unlabelled liposomes were overlapping, highlighting the ability of NTA to size fluorescent
particles even when in the presence of unlabelled particles of different size.
Figure 2.7: Size distribution of 50 nm fluorescent liposomes alone (red) or after mixing
(blue) with unlabelled 200 nm (black) liposomes.
"diffraction" and "fluorescence" indicate the absence or presence of a fluorescence filter for
particle detection
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The experiment was repeated with 200 nm fluorescent liposomes to confirm that the sizing
of larger fluorescent liposomes (Fig. 2.8, blue curve) was also accurate when mixed (Fig. 2.8,
red curve) with small, unlabelled liposomes (Fig. 2.8, black curve). This experiment yielded
similar results to the previous one, confirming that NTA can size both small or large sub-
populations of fluorescent liposomes in the presence or absence of unlabelled liposomes of
a different size.
Figure 2.8: Size distribution of 200 nm fluorescent liposomes alone (red) or after mixing
(blue) with unlabelled 100 nm (black) liposomes.
"diffraction" and "fluorescence" indicate the absence or presence of a fluorescence filter for
particle detection
These experiments demonstrated several advantages of NTA compared to other available
sizing techniques. NTA is a single-particle method that can size large populations. NTA
was also able to accurately and precisely size calibration beads in a biologically relevant size
range and was better at distinguishing two populations of similar sizes present in a mixed
population. Finally, NTA was able to specifically detect and size a subset of liposomes
within a population. These properties of NTA confirm its usability as a tool to measure
curvature sensitivity of proteins.
2.2.3 BAR domain curvature sensitivity
After having confirmed NTA sizing abilities, I then needed a proof of principle that NTA
could be used to measure curvature sensitivity of proteins. Thus I started by using lipid-
binding domains with known curvature preferences. Bin/Amphiphysin/Rvs (BAR) do-
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mains are elongated dimers forming six-helix bundles with different curvatures [287, 55, 58].
Curvature preferences for several BAR domains have been determined using liposome co-
sedimentation or flotation assays and correlate with their three-dimensional structures.
The flatter the domain is, the larger are the liposomes it preferentially binds to. En-
dophilin A (SH3GL1/2/3) forms highly curved banana-shaped dimers [288] and was previ-
ously shown to preferentially bind small liposomes [26]. Endophilin however also contains
an N-terminal amphipathic helix and has been shown to generate curvature, producing
smaller vesicles or tubules [26, 65, 289]. I nevertheless chose Endophilin A2 as my first
test protein, considering that under the low protein concentrations needed to work in NTA
(1-5 nM), vesiculation and tubulation might be negligible. This assumption was tested
below before proceeding with further experiments on curvature sensitivity.
Rat Endophilin A2 N-BAR labelled on the only available cysteine at Q228C with Alexa488R©-
maleimide, a kind gift from Emma Evergren who purified and labelled it, was used in this
study [290]. Size distribution of liposomes alone under diffraction was recorded (Fig. 2.9,
black curve). After addition of protein, the size distribution was measured under fluores-
cence (Fig. 2.9, red curve) to check curvature sensitivity of Endo NBAR-488 on liposomes
of defined composition (for details see Material & Methods (chapter 5)). In this measure-
ment, all fluorescent liposomes (i.e. Endophilin-bound liposomes) are detected and sized.
The measurement is then repeated in diffraction mode (Fig. 2.9, blue curve) to check for
vesiculation by Endophilin. Given the similar size distributions of liposomes in the absence
(Fig. 2.9, black curve) or presence (Fig. 2.9, blue curve) of Endo NBAR-488, at the low
protein concentrations used for NTA, I concluded that Endo NBAR-488 did not vesiculate
liposomes and could therefore be used as a candidate for curvature sensitivity. As ex-
pected from its three-dimensional structure and published data [26, 288], Endo NBAR-488
preferentially bound small liposomes (Fig. 2.9, red curve).
Using protein labelled at a single site with a small fluorophore provided a clean system to
work with. However, Alexa488 photobleached quickly under the strong laser beam used
for NTA, so other fluorophores were tested for high fluorescent intensity and slow photo-
bleaching under NTA conditions. The best candidate was found to be superfolder Green
Fluorescent Protein (sfGFP) [291]. In addition to its brightness and slower photobleaching,
it allows for higher throughput in protein production, as candidate proteins can be directly
purified as fusion proteins with sfGFP, thereby reducing the number of purification steps
required. Before using sfGFP routinely as a fluorophore for NTA, I checked that a 27kDa
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Figure 2.9: Curvature preference of Endo NBAR-488. Size distributions of liposomes
alone (black), fluorescent (red) or all (blue) particles after addition of Endo NBAR-A488
"diffraction" and "fluorescence" indicate the absence or presence of a fluorescence filter for
particle detection
tag, which is of similar or larger size than most lipid-binding domains used, did not change
curvature sensitivity of protein binding. I therefore compared Endo NBAR-488 and Endo
NBAR-sfGFP curvature preferences (Fig. 2.10, blue and red curves). Both fluorophores
resulted in very similar curvature preferences, validating the use of sfGFP for NTA.
Figure 2.10: Comparison of Alexa488 and sfGFP for NTA curvature sensitivity mea-
surements. Size distributions of all liposomes (black), Endo NBAR-sfGFP (red) or Endo
NBAR-Alexa488 (blue) bound liposomes.
"diffraction" and "fluorescence" indicate the absence or presence of a fluorescence filter for
particle detection
To confirm Endophilin preference for small liposomes, the experiment was repeated using
liposomes extruded to 250 nm diameter (Fig. 2.11, blue), 150 nm (red) or 80 nm (green) as
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inputs. Data representations as size distributions (Fig. 2.11A) or box plots (Fig. 2.11B)
clearly show that Endophilin preferentially binds to the smallest available liposomes.
Figure 2.11: Curvature sensitivity of Endo NBAR-sfGFP. A. Size distributions of all
liposomes (darker colours) or Endo N-BAR-sfGFP bound liposomes only (ligher colours)
or 250 nm (blue), 150 nm (red) or 80 nm liposomes.
B. Box plot representation of the same data
These results were also validated by using the published method of liposome flotation
assay [77, 292]. Endo NBAR-sfGFP was incubated with 250 nm or 80 nm or without ()
liposomes, then samples were mixed with a gradient medium and layered with a density
gradient as described in Material & Methods (chapter 5). During ultracentrifugation,
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proteins stayed at the bottom of the tube, while liposomes rose to the surface, carrying
bound proteins if any. With 250 nm liposomes, as in the absence of liposomes (Fig. 2.12,
250 nm, ), Endo NBAR-sfGFP was primarily found in the bottom two fractions, whereas
when using 80 nm liposomes, Endophilin could also be detected in the top fraction. This
experiment also confirmed Endophilin's preferential binding to smaller liposomes.
Figure 2.12: Curvature sensitivity of Endo NBAR-sfGFP by liposome flotation assay in
the absence () or presence of 250 nm or 80 nm liposomes.
Endophilin binding to membranes is increased by negatively charged lipids (like phos-
phatidylserine PS) and PI(4,5)P2 [293]. I wanted to test the effect of lipid composition, in
particular PI(4,5)P2 concentration on curvature sensitivity of Endophilin. Liposomes used
routinely for experiments with Endophilin contain 2% PI(4,5)P2, and I also measured its
curvature preference in the absence (0%) or in the presence of 5% PI(4,5)P2 (Fig. 2.13).
With increasing concentrations of PI(4,5)P2, Endophilin preference for small liposomes,
although still present, became less stringent and increasingly larger liposomes could also
be bound.
Having confirmed that Endophilin preferentially bound to smaller liposomes, I tested other
BAR domain proteins with different curvature preferences, FCHo2 (Fes and Cip4 Homol-
ogy domain Only 2) and Insulin receptor substrate p53 IRSp53 (BAIAP2 Brain-specific
angiogenesis inhibitor 1-associated protein 2). FCHo2 has an F-BAR domain which is
less curved than Endophilin NBAR (Fig. 2.14 middle versus left) and has been shown to
be curvature insensitive and bind all sizes of liposomes equally [56]. On the other hand,
IRSp53 is an I-BAR protein (inverted BAR, also called IMD for IRSp53-MIM homology do-
main) [294] and is relatively flat (Fig. 2.14 right) [57]. IRSp53 is enriched on and stabilises
negative membrane curvature [100].
For FCHo2, an extended construct comprising the BAR domain and part of the unstruc-
tured region at its C-terminal was used to increase lipid-binding properties (as suggested in
[107]). This construct containing residues 1-324 is hence called BARX for extended BAR.
As for Endophilin, a fusion construct with sfGFP was used. Despite using the extended
construct, binding affinity was lower than observed for Endophilin, especially to 200 nm
liposomes (Fig. 2.15, blue). As it was hard to judge the exact curvature preference on 120
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Figure 2.13: Influence of PI(4,5)P2 content on curvature sensitivity of Endophilin. A.
Size distribution of liposomes input (dotted lines) and Endophilin-bound liposomes only
(solid lines) at different concentrations of PI(4,5)P2. B. Box plot representation of the
same data.
Figure 2.14: Comparison of BAR domain curvatures from Endophilin [295], FCHo2 [56]
and IRSp53 [57]
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and 80 nm liposomes (Fig. 2.15, red and green), data were normalised (Fig. 2.15B) and
showed that FCHo2 indeed bound liposomes equally irrespective of their sizes.
Figure 2.15: A. Curvature sensitivity of FCHo2 BARX-sfGFP. B. Normalised data for
120 and 80 nm liposomes.
As IRSp53 binds to negative membrane curvature, I expected it to preferentially bind
to larger liposomes with less positive curvatures. In a similar experiment as the one used
with Endophilin and FCHo2, I tested IRSp53 BAR-sfGFP binding to liposomes of different
sizes (Fig. 2.16). IRSp53 BAR-sfGFP bound to the largest possible fraction of the 200 nm
liposomes with a peak around 350 nm. No binding was observed for 120 and 80 nm. This
could be explained by the absence of large enough liposomes for binding. The small peaks
observed around 50 nm with IRSp53 BAR-sfGFP in the presence of 120 or 80 nm is of
similar intensity as the one without addition of liposomes, therefore corresponding to a
small fraction of aggregated protein.
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Figure 2.16: Curvature sensitivity of IRSp53 BAR-sfGFP
The experiments with BAR domains of known curvature sensitivity of Endophilin, FCHo2
and IRSp53 confirmed that NTA is a valid technology to measure curvature sensitivity of
lipid-binding domains.
2.2.4 Curvature sensitivity of other lipid-binding domains
Having demonstrated that NTA can be used to measure curvature sensitivity of protein
binding to membranes, the next step was to expand the range of curvature sensitive do-
mains to non-BAR lipid-binding domain families. The initial plan was to test proteins
from all known lipid-binding families. Discoidin C2 and γ-carboxyglutamate rich (Gla)
domains were excluded from the screen as they are extracellular proteins carrying post-
translational modifications (disulfide bonds for discoidin C2 [296] and vitamin K dependent
γ-carboxyglutamate for Gla domains [297]) that would make protein production in E. coli
impractical. The resulting list of candidate domains I started with is found in table 2.2.
For some of these constructs, cloning failed due to low concentration of the corresponding
cDNA in the libraries used. For others, expression in E. coli was very low or the resulting
purified protein was unstable. This resulted in the following list of purified soluble sfGFP
fusion proteins (Tab. 2.3).
As for every experiment using NTA, I started by checking signal from protein alone (in the
absence of lipids). Some of the domains showed high concentrations of aggregates. This
was surprising as construct boundaries were chosen whenever possible based on domains
for which a crystal structure had been obtained. Furthermore, proteins were purified using
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Table 2.2: Lipid-binding domains planned for this study
BAR PHD C1 FYVE GRAM
Endophilin A2 ING2 PKCδ HRS MTMR2
Amphiphysin1 ACF1 PKCβ2 EEA1 OXR1
FCHo2 WDFY3
IRSp53 PTB C1-C2 PROPPIN
Dab2 PKCβ2 FERM WIPI1
BAR-PX IRS1 FAK1 WDR45B
SNX9 C2 Talin1
PX PLCδ1 KRIT1 Annexin
PH NCF4 cPLA2 AnnexinA1
AKT SGK3 Synaptotagmin1 ENTH/ANTH AnnexinA4
PLCδ1 AP180 AnnexinA7
CYTH3 PDZ C2-Gaq Epsin1
PICK1 PLCβ1b Others
MICALL1
NECAP1 PHear
Table 2.3: Purified lipid-binding domains
BAR PH C1 FYVE Annexin
Endophilin A2 AKT PKCδ HRS AnnexinA7
Amphiphysin1 PLCδ1 PKCβ2 EEA1
FCHo2 CYTH3 WDFY3 ENTH/ANTH
IRSp53 C1-C2 AP180
PTB PKCb2 FERM Epsin1
BAR-PX Dab2 FAK1
SNX9 IRS1 C2 Talin1 Others
cPLA2 MICALL1
GRAM PX Synaptotagmin1 NECAP1 PHear
OXR1 SGK3
size exclusion chromatography which in all cases eluted after the void volume, indicating
a soluble state.
Several methods were tried to remove the aggregates, with varying levels of success. The
easiest way was to increase salt concentration (the buffer used for NTA, NS, contained
100mM NaCl) or to use buffer additives as described in [298]. I tried different concen-
trations of kosmotropes and chaotropes using IRSp53 BAR-sfGFP as a test candidate.
Increasing NaCl concentration to 150mM (Fig. 2.17, dark blue) decreased the number of
IRSp53 BAR-sfGFP aggregates, while 500mMmM NaCl (Fig. 2.17, blue) abolished aggre-
gates. Addition of 100mM LiCl or KCl (Fig. 2.17, green, khaki) decreased the number
of aggregates to similar levels as 150mM NaCl while salts containing divalent ions like
CaCl2 (Fig. 2.17, dark red), MgSO4 (Fig. 2.17, purple) and (NH4)2SO4 (Fig. 2.17, pink)
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suppressed aggregates already at 100mM. To test how efficient CaCl2 was to reduce ag-
gregates, lower concentrations were also tested. 50 (Fig. 2.17, red) and even 10mM CaCl2
(Fig. 2.17, orange) were sufficient to completely abolish aggregates.
Figure 2.17: Effect of salt additives on aggregates of IRSp53 BAR-sfGFP
I then tested if those buffer conditions were suitable for measurements of curvature prefer-
ence of membrane binding on NTA. I chose 200mM NaCl (NS+100mM NaCl, Fig. 2.18,
green) and 10mM CaCl2 (Fig. 2.18, red) as additives. Although both reduced aggregates
(Fig. 2.18, dark red and dark green), they both also interfered with binding of IRSp53
BAR-sfGFP to liposomes (Fig. 2.18, light red and light green), as no binding could be
observed any more. In addition, high salt and calcium ions promote liposome aggregation
and fusion [299], making this strategy unsuitable for measurements with liposomes.
I then tried another way to reduce unspecific protein-protein interaction resulting in aggre-
gates by adding an inert carrier protein, in this case His-SUMO. For this experiment I used
C1BC2 domain of PKCβ2 fused to sfGFP, PKCβ2 C1BC2-sfGFP (Fig. 2.19). 1.1µM His-
SUMO was enough to suppress aggregates (Fig. 2.19, dark red), whereas 0.11µM His-
SUMO increased the size of observed aggregates (Fig. 2.19, dark blue). As 1 nM PKCβ2
was used in this experiment, a 1000-fold excess of His-SUMO was necessary to abolish
aggregates. However, addition of 1.1µM His-SUMO also impaired binding to liposomes
(Fig. 2.19, light red).
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Figure 2.18: Effect of salt additives on binding of IRSp53 BAR-sfGFP to liposomes
Figure 2.19: Effect of addition of His-SUMO on PKCβ2 C1BC2-sfGFP aggregation and
binding to liposomes
As a last resort, I tried to filter protein using spin concentrators with 100 or 300 kDa
molecular weight cut-off. In some cases it reduced aggregates, in other cases, no protein
came through as either the whole protein formed aggregates or the protein stuck to the
filter. Ultimately, for proteins showing heavy aggregation, the easiest and safest way was
to purify them again by nickel affinity chromatography followed by size exclusion.
Out of the 27 expressed sfGFP-lipid-binding domains, 19 were soluble and could be assayed
for their curvature sensitivity (Tab. 2.4). Three (PLCδ1 PH, SGK3 PX and MICALL1)
showed high aggregation that I could not suppress by any of the above strategies. Those
were excluded from further analysis. Seven other domains (FAK1 FERM, Talin1 FERM,
Dab2 PTB, Synaptotagmin1 C2, AP180 ANTH, Epsin1 ENTH and OXR1 GRAM) that
still had significant levels of aggregates were nonetheless kept with caution (Tab. 2.4 itali-
cised).
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Table 2.4: Soluble lipid-binding domains
BAR PH C1 FYVE Annexin
Endophilin A2 AKT PKCδ HRS AnnexinA7
Amphiphysin1 CYTH3 PKCβ2 EEA1
FCHo2 WDFY3 ENTH/ANTH
IRSp53 PTB C1-C2 AP180
Dab2 PKCβ2 FERM Epsin1
BAR-PX IRS1 FAK1
SNX9 C2 Talin1 Others
GRAM cPLA2 NECAP1 Phear
OXR1 Synaptotagmin1
After sorting out the aggregation problems, I started measuring curvature sensitivity for
these lipid binding domains, using a 1:1 mixture of Sigma Folch and Avanti polar brain
lipids (FolchSA) as an initial lipid composition. Although I could observe significant bind-
ing for some protein domains like ANTH-sfGFP (Fig. 2.20, red), no binding was observed
for other proteins like Annexin A7-sfGFP or CYTH3 PH-sfGFP (Fig. 2.20, blue, green).
Interestingly, in this preliminary experiment ANTH-sfGFP showed preference for high cur-
vatures as it was preferentially binding smaller liposomes (Fig. 2.20, red).
Figure 2.20: Binding of ANTH-sfGFP, Annexin A7-sfGFP and CYTH3 PH-sfGFP on
FolchSA liposomes
As only a few domains bound tightly enough to FolchSA under NTA conditions, I looked in
the literature for specific interactions or preferences of lipid-binding domains for headgroups
as a way to increase binding affinity. FYVE domains have a preference for PI(3)P [140, 185]
and FERM domains for acidic phospholipids or PI(4,5)P2 [170]. Annexins also prefer
acidic phospholipids [179]. C1 domains specifically bind DAG (diacylglycerol) or, with
stronger affinity, its analogue PMA (phorbol 12-myristate 13-acetate) [300], whereas C2
domains have more diverse preferences: cPLA2 binds PC [301], Synaptotagmin1 C2 prefers
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PI(4,5)P2 and negatively charged lipids [302, 28]. PH and PTB domains generally bind
to phosphoinositides; AKT was reported to bind to PI(3,4)P2 or PI(3,4,5)P3 [303, 304],
CYTH3 binds to PI(3,4,5)P3 [305], Dab2 PTB binds PI(4,5)P2 [164, 163], whereas IRS1
PTB binds either PI(4,5)P2 or PI(3,4,5)P3 [306].
Figure 2.21: Binding of lipid-binding domains on FolchSA spiked with 2% PI(3)P (A),
PI(4,5)P2 (B), PI(3,4,5)P3 (C) or 5% PS (D)
In order to increase the binding of domains to liposomes, I decided to spike the current
liposome composition, FolchSA, with the appropriate headgroup for each domain. I there-
fore used 2% PI(3)P (Fig. 2.21A), PI(4,5)P2 (Fig. 2.21B) or PI(3,4,5)P3 (Fig. 2.21C) or 5%
PS (Fig. 2.21D). HRS FYVE-sfGFP displayed binding, albeit low, to FolchSA+2% PI(3)P
liposomes (Fig. 2.21A, green), but neither EEA1 nor WDFY3 FYVE-sfGFP (Fig. 2.21A,
red, blue) bound to those liposomes. On FolchSA+2% PI(4,5)P2 liposomes, Dab2 PTB-
sfGFP showed binding (Fig. 2.21B, dark blue) despite a lot of aggregates, however IRS1
PTB-sfGFP (Fig. 2.21B, purple) did not. IRS1 PTB-sfGFP did not significantly bind
to FolchSA+2% PI(3,4,5)P3 either (Fig. 2.21C, purple), however AKT PH-sfGFP did
(Fig. 2.21C, light blue). Finally, on FolchSA+5% PS, both FAK1 and Talin1 FERM,
despite some aggregates, showed some binding (Fig. 2.21D, blue and red). On the other
hand, Annexin A7-sfGFP did not bind to FolchSA+5% PS in the presence of a five-fold
excess of CaCl2(Fig. 2.21D, green). In these preliminary experiments, several lipid-binding
domains showed signs of curvature preference. HRS FYVE-sfGFP peak was slightly shifted
towards smaller liposomes compared to the input distribution (Fig. 2.21A, green). AKT
PH-sfGFP displayed tighter binding to smaller liposomes as well (Fig. 2.21C, light blue).
FAK1 and Talin1 FERM-sfGFP-bound liposomes, on the other hand, were slightly larger
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than the input distribution, indicating a preference for less positively curved membranes
(Fig. 2.21D, blue and red).
Although FAK1 and Talin1 FERM showed some binding to FolchSA+5% PS (Fig. 2.21D,
blue and red), this could potentially be increased with higher amounts of PS. Therefore, I
tried very high concentration of PS, 50% in Sigma Folch (FolchS), to check if any strong
binding occurred with 2 nM protein. Binding could indeed be observed both for FAK1
(Fig. 2.22, blue) and Talin1 (Fig. 2.22, red) FERM-sfGFP.
Figure 2.22: Binding of FAK1 and Talin1 FERM-sfGFP on FolchS-50% PS liposomes
I finally tested binding of PKCβ2 C1B-sfGFP and C1BC2-sfGFP. To improve binding,
50% PS and 3% PMA (a diacylglycerol analogue to which C1 domains bind with higher
affinity) in FolchS was used (Fig. 2.23). Both constructs displayed similar binding to this
liposome composition.
Figure 2.23: Binding of PKCβ2 C1B-sfGFP and C1BC2-sfGFP on FolchS-50% PS+3%
PMA liposomes
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In order to differentiate binding by C1B domain only from coordinated binding from both
C1B and C2 domains, I first wanted to ensure that binding of PKCβ2 C1BC2-sfGFP indeed
occurred through both domains, despite high concentrations of PS and PMA used. As C2
domain binding to lipids is calcium dependent, I investigated the binding in the presence
of CaCl2 versus EDTA (Fig. 2.24). Binding was similar in the presence of a five-fold excess
of calcium (blue) or of EDTA (purple). Even in the presence of a 1000-fold excess of EDTA
(pink), it was only marginally reduced, indicating that binding occurs primarily through
C1B and that C2 does not contribute significantly. In order to check binding of C1B versus
C1BC2, a different lipid composition with lower PS and PMA should therefore be used.
Figure 2.24: Effects of CaCl2 and EDTA on binding of PKCβ2 C1B-C2 domain on
FolchS-50% PS+3% PMA liposomes
Based on those preliminary experiments, for some lipid-binding domains, I could determine
appropriate lipid compositions for which binding could be observed in NTA (Tab. 2.5).
I then started investigating their curvature preferences. For this, I used liposomes of
composition identified above, extruded at three different sizes, resulting in 200 nm, 120 nm
and 80 nm particles. This allowed me to check the consistency of the curvature preferences
between different sizes. It also made identification of curvature insensitive domains easier
as they would bind equally to every size distribution of input liposomes.
I thus checked curvature sensitivity of HRS FYVE-sfGFP binding to FolchS+2% PI(3)P
(Fig. 2.25). Unlike BAR domains, HRS FYVE-sfGFP did not display any striking cur-
vature preference and was found to bind all sizes of liposomes. However, for all three
sizes of liposomes, the peak of HRS binding was to slightly smaller sizes than the input
distribution, possibly indicating a slight preference for higher curvatures.
The next candidate domain was PKCβ2 C1B-sfGFP. Its curvature preference was measured
on FolchS-50% PS+3% PMA liposomes (Fig. 2.26). PKCβ2 C1B-sfGFP was found on all
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Table 2.5: Lipid-binding domains with corresponding lipid composition for NTA assays
Construct Lipid composition
Endophilin A2 BAR FolchSA
Amphiphysin1 BAR FolchSA
FCHo2 BARX FolchSA
IRSp53 BAR FolchSA
AP180 ANTH FolchSA
Epsin1 ENTH FolchSA
AKT PH FolchS+5% PI(3,4,5)P3
Dab2 PTB FolchS+2% PI(4,5)P2
HRS FYVE FolchS+2% PI(3)P
FAK1 FERM FolchS-50% PS
Talin1 FERM FolchS-50% PS
PKCβ2 C1B FolchS-50% PS+3% PMA
Figure 2.25: Curvature sensitivity of HRS FYVE-sfGFP binding to FolchS+2% PI(3)P
liposomes. Mean ± SEM, n=3
sizes of liposomes when using 150 nm liposomes (blue). On the other hand, when using
120 nm liposomes (red), PKCβ2 C1B-sfGFP showed a peak binding closer to 80 nm.
I then assessed FAK1 and Talin1 FERM-sfGFP curvature sensitivity on FolchS-50% PS
liposomes (Fig. 2.27, 2.28). When using 200 nm liposomes (blue) both FERM domains
bound to all sizes. In the case of Talin1 FERM-sfGFP, the concentration of fluorescent
liposomes in the presence of Talin1 FERM-sfGFP was similar to the input concentration of
liposomes, indicating that all liposomes present had Talin1 FERM-sfGFP bound, whereas
for FAK1 FERM-sfGFP, the concentration of fluorescent liposomes was lower than the
total input. This might indicate that Talin1 FERM had a higher affinity for FolchS-50%
PS liposomes.
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Figure 2.26: Curvature sensitivity of PKCβ2 C1B-sfGFP binding to FolchS-50% PS+3%
PMA liposomes. Mean ± SEM, n=3
Both constructs behaved similarly when added to 120 nm liposomes (Fig. 2.27, 2.28 red);
they bound preferentially the smaller end of the size distribution with a maximum binding
efficiency close to 100 nm. On 90 nm liposomes (Fig. 2.27, 2.28, green), both FAK1 and
Talin1 preferentially bound smaller liposomes with a peak around 80 nm.
Figure 2.27: Curvature sensitivity of FAK1 FERM-sfGFP binding to FolchS-50% PS
liposomes. Mean ± SEM, n=3
The last domain I checked was the PH domain of AKT. I used Sigma Folch liposomes
supplemented with 2% PI(3,4,5)P3 (Fig. 2.29). AKT PH-sfGFP consistently preferentially
bound to smaller liposomes than the input distribution, indicating preference for higher
curvature, a fact that has not been reported to date.
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Figure 2.28: Curvature sensitivity of Talin1 FERM-sfGFP binding to FolchS-50% PS
liposomes. Mean ± SEM, n=3
2.2.5 Vesiculation by ENTH
Having shown how NTA could be used to measure curvature sensitivity of protein binding,
I was curious to test if it could also be used to test aspects of membrane remodelling. For
this I chose the ENTH domain of Epsin1 as a model candidate. ENTH can form tubules
(tubulation) or smaller vesicles (vesiculation) after addition to liposomes [24]. In addition,
Ford et al. identified a mutant in the amphipathic helix, L6W, that increased vesiculation
over tubulation.
The first test was to check if I could observe a reduction in size of liposomes after incubation
with ENTH (Fig. 2.30). Both ENTH wild-type (wt) and L6W mutant induced a reduction
in size of liposomes after incubation. In addition, L6W mutant generated a higher number
of small vesicles than the wild-type.
As NTA could detect vesiculation, the next step was to test the effect of ENTH dose on
vesiculation. For this, liposomes were incubated with different concentrations of ENTH,
either wild-type or L6W mutant, then sized (Fig. 2.31). Increase in concentration of small
liposomes was dependent on the concentration of ENTH added for both ENTH wild-type
(Fig. 2.31A) or L6W mutant (Fig. 2.31B).
In order to quantify the dose-response of ENTH vesiculation, the concentration of liposomes
in the bin with the maximum concentration (here 5 nm bin with centre around 82.5 nm
indicated by the dotted black line) was extracted from the data and plotted as function of
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Figure 2.29: Curvature sensitivity of AKT PH-sfGFP binding to FolchS-2% PI(3,4,5)P3
liposomes. A. Size distributions of liposomes input (darker curves) and AKT PH-sfGFP
bound liposomes only (lighter curves). Mean ± SEM, n=3. B. Box plot representation of
the same .
ENTH concentration (Fig. 2.32). The curve followed a typical dose-response and maximal
response (top), inflection point and Hill coefficient were read (Tab. 2.6). ENTH wild-type
and L6W showed a similar inflection point (5µM for wild-type and 4µM for L6W) but
mostly differed in their maximum response, which was higher for L6W (3.2·107/ml) than
wild-type (2.6·107/ml), confirming the higher vesiculation efficiency of ENTH L6W mutant
over wild-type.
Table 2.6: Dose-response curve of ENTH vesiculation
ENTH wt ENTH L6W
Top (107/ml) 2.6(2) 3.20(13)
Inflection (µM) 4(1) 5(1)
Hill coefficient 3.4(1.4) 3.7(8)
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Figure 2.30: Size reduction of liposomes after incubation with ENTH wild-type (wt) or
L6W
Figure 2.31: Dose-response of vesiculation with ENTH wt (A) or L6W (B)
Figure 2.32: Dose-response curve of vesiculation with ENTH wild-type (wt) or L6W
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As the dose-response of ENTH vesiculation could be studied by NTA, I then tried if kinetics
of vesiculation could also be followed by NTA. For this, I incubated liposomes with ENTH
and took aliquots at different time points for analysis. These aliquots were diluted 500-
fold in NS buffer, the dilution required to reach the required total particle concentration
for analysis by NTA, then sized by NTA (Fig. 2.33). At the 10 seconds time point, the
reaction was still in progress. After 20 seconds, the reaction was already over as there was
no increase in the concentration of small liposomes after longer incubations. Accurately
measuring kinetics of reactions happening within tens of seconds using NTA is difficult due
to time needed for manual mixing of samples and should be left for faster methods.
Figure 2.33: Time-course of ENTH vesiculation after addition of 2µM ENTH wild-type
2.3 Discussion
Membrane shape of subcellular structures is important for their function. Increasing ev-
idence supports the role of membrane curvature for protein localisation and regulation
[307, 308]. Here I have described the development of a new method to test the curva-
ture sensitivity of protein binding to membranes. I showed that Nanoparticle Tracking
Analysis (NTA) could reproduce both published curvature preferences for several BAR
domain proteins as well as results obtained from liposome flotation assay with Endophilin.
Among the non-BAR lipid-binding domains tested, most bound all sizes of liposomes non-
selectively and did not show a strong preference for any particular curvature. The PH do-
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main of RAC-alpha serine/threonine-protein kinase (AKT), however, preferentially bound
to smaller liposomes, a previously unreported observation.
NTA tracks single particles and calculates their size based on Brownian motion equation.
Compared to Dynamic Light Scattering (DLS), NTA was both more precise and more
accurate (Fig. 2.5 versus 2.6). In addition, NTA was better at sizing a mixed population.
This probably derives from the fact that DLS produces a bulk measurement, whereas NTA
is a single-particle method. In addition, NTA measurements did not suffer as much as DLS
from bias introduced by contaminations by a small fraction of larger, highly diffracting,
particles.
Nevertheless, some aspects of NTA equipment and software could be improved. During
analysis of the NTA videos, three parameters are set automatically. "Blur" sets smoothing
of pixels around a particle to reduce noise. "Max jump distance" sets the maximal radius
around a particle where it should be found in the following frame. "Min track length"
sets the minimal number of frames a particle has to be tracked in order to be included in
the analysis. Although automatically chosen values for each parameter are generally good,
they might be different for each movie, especially in recordings with protein alone (which
mostly contains residual small aggregates) versus protein-liposome mix. In order to unify
processing of the data within an experiment, it would be good to keep those parameters
consistent, i.e. to manually set for movies with protein alone the values automatically
chosen for movies with protein-liposome mix. However only values for max jump distance
are indicated on the results. It is then not possible for the user to manually input values
for blur and min track length as those are only reported as "auto". Although this would
prevent the bias towards smaller particles when measuring protein alone, it does not affect
the results from measurements of protein-liposome mixes.
In the current setup, the size of all liposomes is measured by diffraction and, following
mixing with fluorescent protein, the size of fluorescent, protein-bound, liposomes only
is measured under fluorescence mode. Comparison of both size distributions indicates
curvature preference. Further analysis could be performed using the fluorescent intensity
of each particle, which is proportional to the number of protein molecules bound to a
liposome. These data would allow determination of the surface density of proteins as a
fonction of liposome size and curvature. Although fluorescent intensity of each particle is
measured for each frame, it is not straightforward to use this information. As particles are
flown through the sample chamber and the observation volume, they move not only in x and
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y dimensions but also in z, in and out of focus, resulting in a variable recorded fluorescence
intensity. In addition, photobleaching occurs due to the high power laser, despite the use of
a pump to continously flow sample. Between z movement and photobleaching, extracting
the actual fluorescence intensity of a particle is difficult but could be attempted. During
an NTA experiment, several parameters are recorded for each particle, namely diffusion
coefficient and fluorescence intensity for each frame. The current analysis relies on the NTA
software that provides the number of particles per bin size only. Further developments will
be done to improve the analysis performed to better fit our questions.
Measurements of curvature sensitivity of protein binding to membranes using NTA were
heavily influenced by protein-specific characteristics. NTA can detect particles as small as
10 nm [286] and will pick up signal from any diffracting or fluorescent particle, depending on
the insertion of a fluorescence filter. As such, presence of protein aggregates will interfere
with accurate measurements. A surprisingly high proportion of sfGFP-fusion lipid-binding
domains purified here (about a third of the domains from the initial purification round)
showed presence of aggregates. Causes can range from rough treatment during purification,
concentration, freezing or thawing of the protein, choice of construct boundaries (although
they were chosen whenever possible to match those used for structure determination by
crystallisation) or interference of the GFP fusion with protein stability. Increasing salt
concentration helped reduce the concentration of aggregates (Fig. 2.17), hinting at ag-
gregation resulting from electrostatic interactions, but in turn also significantly reduced
binding to liposomes (Fig. 2.18), making this of little use for routine measurements of cur-
vature sensitivity with NTA. No general solution against aggregates has been found yet,
although careful procedures during concentration and thawing of protein seemed the most
helpful. This nevertheless raises a caution with NTA results where a protein preferentially
binds to high curvatures, as NTA is unable to distinguish between protein aggregates and
protein bound to small liposomes. NTA results should therefore be further validated with
a different method.
Another important decision to make while using NTA for measuring curvature sensitiv-
ity is the choice of fluorophore for lipid-binding domains. Here, superfolder Green Flu-
orescent Protein (sfGFP) [291] was chosen to streamline purification by eliminating the
need of additional steps for labelling with an organic fluorophore. Despite its large size,
27kDa, similar or larger than most lipid-binding domains used in this thesis, sfGFP fu-
sion Endophilin NBAR had similar curvature preference as the Alexa488-labelled protein
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(Fig. 2.10). sfGFP or Alexa488 turned out to be good choices as two studies showed that
some organic dyes display unspecific binding to membranes [309, 310]. Those studies used
eggPC or eggPC:DOPS 9:1 [310] or cell membranes [309] and showed that Alexa488 has
little unspecific binding to membranes unlike for example atto647N. They however pointed
out that unspecific dye binding to membranes is highly dependent on the lipid composi-
tion used, especially its overall charge, as well as the charge and hydrophobicity of the
fluorophore tested. The affinity of sfGFP alone for Folch liposomes was assessed in NTA;
no detectable signal of fluorescent liposomes could be recorded after incubation of Folch
liposomes with sfGFP (data not shown), indicating the suitability of sfGFP under these
conditions.
Lipid composition is the next factor that influences NTA measurements, both in terms
of binding affinity as well as curvature sensitivity. Folch lipids, extracted from brain,
contain a complex mixture of lipids which should reflect natural membrane composition.
However, most non-BAR lipid-binding domains tested here did not bind strongly enough
on Folch liposomes for their curvature preference to be assessed (Fig. 2.20). In order to
detect enough fluorescent liposomes after addition of a lipid-binding domain, the specific
lipid headgroup those domains interact with had to be added, such as 2% PI(3)P for
FYVE domains (Fig. 2.21A), 2% PI(4,5)P2 for PTB domains (Fig. 2.21B), 3% PMA for
C1 domains (Fig. 2.23) or 2% PI(3,4,5)P3 for AKT PH (Fig. 2.21C). For some domains
such as HRS FYVE, Dab2 PTB, PKCβ2C1B or AKT PH, this was efficient and curvature
sensitivity data could be collected, whereas for some other proteins of the same domain
families like EEA1 or WDFY3 FYVE (Fig. 2.21A) or IRS1 PTB (Fig. 2.21B,C), this was
not sufficient and little to no binding was observed.
In NTA assays, fluorescent protein concentrations must be kept low (1-5 nM) to reduce
background fluorescence. This is low compared to binding affinities of small lipid-binding
domains for lipids. For example, yeast PH domains were found to bind to lipids with an
affinity in the range of 1-20µM [162, 311], indicating that the concentrations of protein
used in NTA measurements are around a thousand fold lower than the KD. Similarly, dis-
sociation constants for BAR domain dimers in solution have been measured in the range
of 5-10µM range [58, 26], although others reported subnanomolar affinity for Endophilin
dimers [103]. Using 1-5 nM protein in NTA assays would correspond to a concentration
about a thousand fold lower than the dimerisation KD, nevertheless binding to liposomes
was observed. This would suggest that BAR domains would bind membranes as monomers
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and then dimerise on the membrane, as has been previously postulated [66]. This discrep-
ancy between protein concentration and affinity to lipids might explain why for most small
lipid-binding domains lipid composition had to be carefully adjusted in order to push the
equilibrium towards binding. In addition, liposome concentration has to be in the range of
108-109 particles/ml, corresponding to picomolar concentrations of particles or 10-100 nM
lipids for NTA. For comparison, bulk assays generally use 0.1-1mM lipids and 1µM pro-
tein. Therefore, the protein-to-lipid ratio in NTA experiments is about ten times higher
than in bulk assays. This can reduce the apparent curvature sensitivity by allowing pro-
tein to bind to less ideally curved liposomes. The higher protein-to-lipid ratio would also
favour curvature generation by protein crowding, further decreasing apparent curvature
sensitivity.
Lipid composition also played a role in curvature sensitivity of protein binding. This
was particularly noticeable in the reduction of stringency of curvature preference of Endo
NBAR-sfGFP to liposomes with increasing PI(4,5)P2 (Fig. 2.13). This could be explained
by an increase in binding sites and therefore affinity, which could compensate for the
slightly less ideal curvature of larger liposomes. As this has for now been only tested for
Endophilin NBAR domain, an alternative explanation could be that increasing PI(4.5)P2
facilitates local remodelling by Endophilin, allowing it to comfortably bind on larger lipo-
somes by locally generating its preferred, higher, curvature. To distinguish between these
explanations, this experiment should be repeated with a different protein domain which is
not capable of generating membrane curvature. This however hints at a potential concern
for domains that are detected as being curvature insensitive. It could be possible that they
are able to locally remodel membrane, a phenomenon that would remain unseen by NTA
and most other techniques for measuring curvature sensitivity.
In the case of the FERM domains of Talin1 and FAK1 (Fig. 2.27, 2.28), liposomes con-
taining 50% PS were used in order to obtain high affinity binding. However, this high,
unphysiological, concentration of negatively charged lipid headgroups might mask a curva-
ture preference by providing excess binding sites. Those experiments should be repeated
with lower concentrations of PS, that would still ensure sufficient binding without introduc-
ing artefactual binding sites. Alternatively, curvature sensitivity of those FERM domains
could be tested on liposomes containing 2% PI(4,5)P2 [170].
In practical terms of using NTA as a method to measure curvature sensitivity, it means
that lipid composition should be carefully adjusted for each lipid-binding domain family,
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and potentially even for each domain within a family. This will obviously result in a lower
throughput of screening.
From those preliminary results as well as the literature, it seems that there are two main
ways of sensing curvature for individual proteins [66, 67, 68, 6]. Proteins can have dedicated
domains, BAR domains, that can recognise any curvature given their elongated shape
and mode of lipid binding via several positively charged residues spread along a 20Å-
long rod [26, 69]. Alternatively, if proteins only have to be targeted to highly curved
membranes, a small, economical, amphipathic helix or hydrophobic insertions might suffice
[82, 81]. Protein complexes can also become curvature sensitive, either as oligomers, in
the case of dynamin for example [70], or as heteromeric protein complexes like the class
III phosphatidylinositol-3-kinase PI3KC3 (Vps34) complex I [99].
Some indications of curvature sensitivity were observed in preliminary experiments for
ANTH, HRS FYVE, FAK1 and Talin1 FERM domains and confirmed for AKT PH domain.
However, most small, non-BAR lipid-binding domains studied here showed little to no
curvature preference. Although the screen is still ongoing and will help identify other
curvature-sensitive domains, it seems that for most of those protein domains, curvature
is not the main mode of targeting. Considering their high specificity for lipid headgroups
that are synthesised at very defined locations within a cell (like PI(3)P for FYVE domains
on early endosomes [312]), curvature sensing might be redundant with efficient targeting
mediated by lipid headgroup specificity only.
NTA identified AKT PH domain as a lipid-binding domain that preferentially binds to
highly curved membranes. I therefore looked at AKT PH domain structures to try to
understand how this small lipid-binding domain could sense high curvature. The two known
mechanisms of curvature sensing would be scaffolding through oligomerisation of the PH
domain - considering it does not contain a BAR domain - or by insertion of an amphipathic
helix in hydrophobic defects. The PH domain from AKT has been shown to interact and
form complexes [313], so this mechanism of high curvature sensing could be possible if
after oligomerisation, AKT PH formed a curved scaffold. Comparing crystal structures of
apo-AKT PH (Fig. 2.34A,B orange) with the structure in complex with inositol 1,3,4,5-
tetrakisphosphate (IP4), the water-soluble headgroup of PI(3,4,5)P3 (Fig. 2.34A,B blue)
[314] shows that upon binding to IP4, a previously flexible loop forms an α-helix. However,
this helix, consisting of residues DVDQREA, is not amphipathic. Curvature sensing could
instead be mediated by insertion of hydrophobic amino acids. Indeed, Trp22 and most
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especially Tyr18, located in a loop, could sense lipid packing defects (Fig. 2.34C, cyan). All
these potential mechanisms of curvature sensing by AKT PH should be further investigated.
Figure 2.34: Crystal structures of AKT PH in absence (orange) and presence (blue) of IP4
[314]. A. Full PH domain. B. Detail of the membrane interaction surface and IP4 binding
region. C. Localisation of Tyr18 and Trp22 (cyan) at the membrane contact interface.
AKT PH domain is specific for PI(3,4)P2 and PI(3,4,5)P3, lipids primarily found in late
endocytosis as well as some areas of the plasma membrane after activation of PI-3-kinases
[315]. AKT is also recruited to EGFR-containing endosomes by Rab5-APPL [316]. As
early endosomes consist of a network of tubules and vesicles [317], areas of high curvature
are common. AKT PH domain preference might be an additional targeting mechanism to
such particular regions on endosomes.
In curvature sensitivity measurements performed using tethered liposomes in SLiC assays,
N-BAR as well as F-BAR and I-BAR proteins were found to preferentially bind higher
curvatures [98]. The authors explained this preference for smaller liposomes to be driven
by amphipathic helices binding into hydrophobic defects, superseding the presence of a
BAR domain. However, in my results using NTA as well as the rest of the literature
including in vivo data, curvature sensing of BAR-domain proteins correlates with the
three-dimensional structure of the BAR domain [26, 56, 69]. This discrepancy between
both sets of results could be explained by differences in experimental setup. Tethering
liposomes to a surface might introduce additional hydrophobic defects, explaining why
in SLiC assays only, curvature sensing via amphipathic helices dominated, even for BAR
domain proteins.
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Here I showed that NTA technology could be used as a tool to characterise curvature sens-
ing of protein binding to lipids. NTA reproduced known curvature preferences of BAR do-
mains and allowed identification of a previously non-reported non-BAR domain curvature
sensor, the PH domain of AKT. NTA was also shown to be a valuable tool to study mem-
brane remodelling, as exemplified for ENTH domain-mediated vesiculation. This could
then be used to characterise newly identified membrane remodelling domains, for example
NECAP1 (Adaptin ear-binding coat-associated protein 1) PH-ear domain [318]. Broad-
ening the screen of non-BAR lipid-binding domains should help identify more curvature-
sensing domains. This knowledge, combined with study of the relative contributions of
Endophilin amphipathic H0 helix versus BAR domain in curvature sensing, should expand
our understanding of how protein domains sense membrane curvature.
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Chapter 3
Endophilin binding motif in
Endophilin-mediated endocytosis
3.1 Introduction
Membrane compartmentalisation provides distinct environments to separate biochemical
processes within the cell and between the cell and its surroundings. However, this sepa-
ration introduces the need for transport systems across membranes. Several mechanisms
have been described for endocytosis [319, 320]. Endocytosis consists of three main phases:
cargo recognition, vesicle formation and membrane scission. Endophilin, a protein formed
of an N-BAR (Bin/Amphiphysin/Rvs) domain followed by an SH3 (Src-homology 3) do-
main, can potentially contribute towards all three steps. Its N-BAR domain can generate
curvature and participate in vesicle formation and membrane fission [26], while its SH3
domain binds cargo and cargo adaptors in fast Endophilin-mediated endocytosis (FEME)
[120]. However, the basis for this recognition by Endophilin SH3 is not clear.
SH3 domains are 50-70 residues long and consist of a five-stranded β-barrel linked by loops
and a short 310 helix (Fig. 3.1A). The canonical binding site on SH3 domains consists of a
shallow hydrophobic groove formed by conserved residues (amino acids displayed in sticks
in Fig. 3.1A) mostly in β3 and β4 strands as well as the tip of the asparagine-threonine
(RT) loop [321, 322].
SH3 domains generally bind proline-rich sequences folded in a polyproline helix type II
(PPII) [324, 325]. PPII helices are all-trans left-handed helices with a perfect three-fold
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Figure 3.1: SH3 binding to polyproline II helix. A. Endophilin SH3 binding site. Residues
lining the binding groove are in sticks (3IQL) [229]. B. Polyproline II helix triangular
prism. C. Models of class I and II SH3 binders on Endophilin showing residues contacting
SH3 (modified from [323]). SH3 subsites where PPII helix residues contact the SH3 are
numbered (P3, P2, P0 and P-1) on the models.
rotational symmetry (Fig. 3.1B). The triangular prism shaped PPII sits on the SH3 on its
base, with two residues per helix turn contacting the SH3 surface. The minimal binding
motif for SH3 was found to be PxxP (P representing prolines and x any residue) [326, 324].
A PxxP motif can bind to SH3 in two opposite orientations, depending on the position of
a positively charged residue on the peptide contacting a negatively charged pocket on the
SH3 surface, the specificity/compass pocket (Fig. 3.1C) [323, 327]. This defines two classes
of SH3 binders. Class I binders are characterised by a +xXPxXP motif (capitalisation
illustrates residues contacting the SH3 surface, + indicate basic residues) and bind C -> N
when facing the SH3 binding groove as in figure 3.1A, whereas class II binders canonically
consist of XPxXPx+ and bind N -> C [326, 324]. Depending on the orientation of the
motif, the proline residues of PxxP are in different positions on the SH3. To facilitate
comparison between SH3 domains, the subsites where the XP motifs bind are numbered
(P3, P2, P0, P-1) (Fig. 3.1C).
Most of the binding energy and therefore specificity is conferred by non-proline residues
that contact the SH3, from both XP motifs as well as the positively charged residue in
the specificity pocket. Although most SH3s prefer Arg in the specificity pocket, some are
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specific for Lys e.g. Crk (CT10 Regulator of Kinase) SH3 [328]. Other SH3 domains have
different preferences. For example, the specificity pocket of Abl SH3 (Abelson tyrosine-
protein kinase 1) lacks conserved negatively charged residues and Abl SH3 accommodates
a hydrophobic residue instead of a basic one [326, 329]. Similarly, some SH3 domains like
PI3K prefer a basic residue like arginine in the central PxRP motif, with that arginine
forming a salt bridge with a glutamate side chain on the RT loop of the SH3 [324]. Other
SH3s lacking acidic residues at those positions like Src SH3 prefer a hydrophobic residue
like leucine [324]. For some ligands, amino acids outside of the core binding motif contact
SH3 residues outside of the peptide binding groove, providing additional specificity [330].
Alternatively, residues next to the core binding motif prevent binding, for example phos-
phoserine, acidic residues or prolines immediately C-terminal to the core binding motif
[331]. For example, autophosphorylation of PAK (p21-activated kinase) prevented binding
by Nck (non-catalytic region of tyrosine kinase adaptor protein 1) SH3 [331]. Although
most SH3 domains bind canonical proline-rich sequences, some SH3 bind with similar
affinities non-consensus peptides. For example, Grb2 C-terminal SH3 (Signal transducing
adapter molecule 2) binds PxxxRxxKP with the central RxxK motif forming a 310 helix
[332, 333] or SKAP55 (Src kinase associated protein of 55 kDa) recognises a RKxxYxxY
motif, lacking any proline [334].
Specificity of Endophilin SH3 has first been studied using phage peptide libraries [335] and
P+RPPxpr was identified as the Endophilin binding motif. Further experiments using
amino acid point substitutions on two proline-rich motifs of the Synaptojanin proline-rich
domain (PRD) lead to xPRRPxPR being recognised as the consensus Endophilin binding
motif [335]. In this consensus sequence, the two "x" represent any amino acid apart from
acidic ones, the first two proline residues can be replaced by phenylalanine, leucine or
isoleucine albeit with reduction of binding, and the last proline can be substituted with
any hydrophobic residue (Phe, Tyr, Trp, Leu, Ile, Val). Similarly, the first and third
arginine residues can be replaced by lysine. This sequence does not fit perfectly either
class I or class II consensus sequence and orientation of the peptide on Endophilin remains
unclear, although Cestra et al. favoured a class I binding [335].
A recent publication investigated the binding of Itch ubiquitin ligase PRD to several SH3
domains using truncation constructs and mutagenesis in GST pull-downs [336]. The affinity
for Endophilin SH3 was measured at KD = 33nM, a high affinity compared to the common
1-100µM affinities for SH3-PRD complexes [337]. Although no crystals were obtained for
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Endophilin SH3  Itch PRD, modelling based on β-PIX  Itch PRD crystal structure and
pull-down data identified Itch(249-258) KPSRPPRPSR as the Endophilin binding motif
binding in N -> C orientation (class II). Although sharing some similarities, this motif
does not conform exactly to the consensus xPRRPxPR identified by Cestra et al. [335],
leaving the question of an Endophilin SH3 binding motif open.
In addition to proline-rich peptides, some SH3 domains also bind folded protein domains,
like ubiquitin [338, 339] or Ubl (ubiquitin-like) domain [229]. An NMR structure of En-
dophilin SH3 and Parkin Ubl complex shows that Parkin Ubl binds in the canonical,
PRD-binding, SH3 groove in a manner reminiscent of SH3-PRD interactions [229]. Al-
though most of the binding is provided by the unstructured C-terminus of Parkin Ubl that
folds upon binding, additional contacts are formed between hydrophobic residues on the
globular Ubl domain and the peptide binding site of Endophilin SH3.
Experiments based on peptide libraries or modelling identified similar but not identical
Endophilin binding motifs, but definitive determinants of Endophilin SH3 specificity are
still lacking. Here I have characterised binding of Endophilin SH3 to cell surface receptors
and adaptor proteins involved in Endophilin-mediated endocytosis and have derived models
of the binding based on NMR data.
3.2 Results
3.2.1 In vitro interaction of adrenergic receptors ICL3 and adaptor pro-
teins with Endophilin
Endophilin A (SH3GL1/2/3) consists of a curvature-generating N-BAR domain and a
SH3 domain (Src homology 3) mediating protein-protein interactions. Endophilin has
recently been described in a clathrin-independent endocytosis pathway responsible for the
uptake of bacterial toxins [119] and activated cell-surface receptors [120]. Endophilin SH3
binds some aminergic G-protein coupled receptors (GPCRs) directly in their intracellular
loop 3 (ICL3), whereas interaction with receptors tyrosine kinase (RTKs) is mediated
by adaptor proteins [120]. Although SH3 domains bind proline-rich domains (PRD), the
exact binding site of Endophilin is unknown. Characterising the binding site would allow a
database search for a similar motif and help identify other cell-surface receptors potentially
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taken up via FEME (fast Endophilin-mediated endocytosis), which would contribute to
understanding this clathrin-independent pathway.
In order to identify suitable candidate proteins for characterisation of the Endophilin bind-
ing site, I confirmed some of the pull-down experiments from Boucrot et al. [120]. For this,
I used GST-tagged fragments of adrenergic receptors ICL3 and adaptor proteins PRDs to
pull-down Endophilin full-length from bacterial lysate overexpressing Endophilin (Fig. 3.2).
Similarly to what Boucrot et al. reported [120], α2A (ADRA2A) and β1 (ADRB1) adrener-
gic receptors were able to pull-down Endophilin, whereas β2 adrenergic receptor (ADRB2)
could not (Fig. 3.2A). As expected, both constructs of CIN85 (Cbl-interacting protein of
85 kDa) as well as Alix (ALG-2-interacting protein X) PRD could pull-down Endophilin
(Fig. 3.2B).
Figure 3.2: Endophilin pull-down by adrenergic GPCRs ICL3 (A) or adaptor proteins
PRD (B).
Potential Endophilin binding sites were further characterised by mutating putative recog-
nition site amino acids to alanine. The effect of a mutation was evaluated by pulling down
EGFP-tagged ICL3 or PRD fragments from cell lysate using GST-SH3 [120], [HMM un-
published] (Tab. 3.1). Mutation of lysine or arginine to alanine in several, distinct sites
of ADRA2A or ADRB1 ICL3 resulted in a decreased pull-down efficiency, suggesting that
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Endophilin SH3 binds on multiple sites on these ICL3. In the case of CIN85 and Alix,
although the screen was not comprehensive, only one putative binding site was identified
(Tab. 3.1).
Table 3.1: Sequences of GPCR ICL3 and adaptor protein PRD tested by mutagenesis
experiments.
Colour scheme represents proline residues in blue and residues affecting (red) or not (green)
pull-down by Endophilin SH3 when mutated to alanine. Mutation data were taken from
[120] or by data from HMM (unpublished).
ADRA2A(299-374) SDHAERPPGPRRPERGPRGKGKARASQVKPGDSLPRRGPGA
TGIGTPAAGPGEERVGAAKASRWRGRQNREKRFTF
ADRA2A(299-339) SDHAERPPGPRRPERGPRGKGKARASQVKPGDSLPRRGPGA
ADRB1(245-314) RVFREAQKQVKKIDSCERRFLGGPARPPSPEPSPS
PGPPRPADSLANGRSSKRRPSRLVALREQKALKT
CIN85(327-412) PPDFEKEGNRPKKPPPPSAPVIKQGAGTTERKHEIKKIPPERP
EMLPNRTEEKERPEREPKLDLQKPSVPAIPPKKPRPPKTNSLS
CIN85(390-428) LQKPSVPAIPPKKPRPPKTNSLSRPGALPPRRPERPVGP
Alix(748-770) PPTKPQPPARPPPPVLPANRAP
Although mutagenesis screen helped pinpoint potential binding site(s), further characteri-
sation was needed, for which two test candidates, one ICL3 and one adaptor protein PRD,
were chosen. Among the adrenergic receptor ICL3 fragments tested, ADRA2A(299-339)
(called ADRA2A from now on) was the shortest construct that bound tightly to Endophilin
(Tab. 3.1) and was more stable than ADRB1 as indicated by the absence of degradation
products (Fig. 3.2A). Among the adaptor protein constructs, Alix(748-770) PRD (called
Alix from now on) was also a good candidate, as it was the shortest construct tested
(Tab. 3.1).
In order to characterise the strength of interaction and evaluate the suitability of those can-
didates for structure determination, the affinity of interaction was measured by isothermal
titration calorimetry (ITC) (Fig. 3.3). Endophilin SH3 affinity for Alix was 1.3±0.2µM
(Fig. 3.3A) and 13±3µM (Fig. 3.3B) for ADRA2A. In both cases, N was close to 1 (0.89
for Alix and 0.91 for ADRA2A), indicating a 1:1 binding. Interestingly, for both peptides,
binding was mostly driven by electrostatics, hydrogen bonds and van der Waals interac-
tions, as −T∆S was small and the enthalpy ∆H provided most of the binding energy ∆G
(as illustrated in figure 3.3C for Alix). The affinity to Endophilin SH3 was sufficient for
both peptides to pursue structural characterisation.
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Figure 3.3: ITC measurements of affinity between Endophilin SH3 and Alix PRD (A)
or ADRA2A ICL3 (B) fragments. Top: released heat, bottom: binding enthalpy. C.
Contributions of ∆H and -T∆S to final ∆G
3.2.2 Endophilin A1 SH3  Alix PRD interaction: NMR model
Chemical shift perturbation analysis
With its low micromolar affinity for SH3, Alix PRD was particularly well suited for struc-
tural studies. Co-crystallisation trials of SH3 Alix were conducted but did not produce any
reproducible crystals. Crystallisation of an SH3-linker-Alix fusion construct did not lead
to any usable crystal for structure determination either. However, as both SH3 (6 kDa)
and Alix (2.8 kDa) are small, this constitutes an ideal system for nuclear magnetic reso-
nance spectroscopy (NMR) studies. All NMR experiments were done in collaboration with
Trevor Rutherford.
An NMR-active nucleus with a spin I = 1/2 exists in two different degenerate states. In a
constant magnetic field B0, nuclear spins align with the field or against the field, generating
two states with different energies. The energy difference between both states is in the
range for photons in the radio frequency (RF) range. Application of RF pulses perturbs
the alignment of the spins with B0. The energy difference between both states depends
on field strength. The corresponding resonance frequency is most commonly expressed
as a frequency ratio, called the "chemical shift", in order to facilitate comparison of data
obtained on machines of different magnetic field strengths. Chemical shift for a resonance
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is sensitive to its local environment, as the movements of surrounding nuclei and electrons
generate a local induced magnetic field. An NMR spectrum is a plot of chemical shifts
[340].
Hydrogen (1H) has a spin of I = 1/2, as do 13C and 15N. As 13C and 15N are naturally rare
isotopes, protein has to be labelled with these isotopes for resonances to be observed in
an NMR spectrum at reasonable protein concentrations. In protein NMR, given the high
number of atoms, NMR spectra are generally recorded in more than one dimension. An
NMR experiment particularly useful for proteins is a 1H-15N HSQC (Heteronuclear Single
Quantum Coherence). In this 1H-15N two-dimensional correlation spectrum, every spot
represents an N-H group, giving information on the magnetic environment of all backbone
amide groups (from all amino acids apart from prolines) as well as side chain N-H of Gln,
Asn and Trp. Changes in the environment give rise to perturbation of the position of
corresponding peaks in the HSQC, which thus provides a sensitive probe for monitoring
the formation of protein complexes.
In the first NMR experiment, the stability and folding state of Endophilin SH3 was checked
by 1H-15N HSQC (Fig. 3.4 red). The 1H resonances were dispersed indicating a well-
folded protein, as in an unfolded region nuclei are in a more similar chemical environment
and 1H resonances tend to cluster [341]. After addition of saturating amounts of Alix
(Fig. 3.4, blue), some SH3 peaks were perturbed (examples indicated by arrows), suggesting
a change in chemical environment following Alix binding. There were, however, no major
conformational changes in the SH3 as most of the chemical shifts remained identical even
after addition of Alix.
SH3 state and chemical shift perturbation (CSP) of some, but not all, residues after addi-
tion of Alix confirmed suitability of NMR for characterisation of Endophilin binding site.
In order to get valuable information on binding site from these spectra, each resonance
peak on the spectra needs to be assigned to a specific N-H group in Endophilin SH3. The
NMR structure of Endophilin SH3 in complex with Parkin Ubl (ubiquitin-like domain) has
been solved and resonance assignments for Endophilin SH3 were obtained [229]. However,
despite performing 1H-15N HSQC under the same conditions, the overlap between both
spectra was not sufficient to use resonance assignments obtained by Trempe et al. [229].
Assignment for SH3 resonances would therefore need to be carried out de novo.
72
Figure 3.4: 1H-15N HSQC overlay of Endophilin SH3 free (red) or with saturating amounts
of Alix (blue). Arrows indicate examples of peaks perturbed upon addition of Alix.
Resonance assignments for proteins is easier with the use of triple-resonance spectra, using
1H, 15N and 13C resonances. In those experiments, magnetisation is not only transferred
from amide 1H to 15N and back but also to the neighbouring carbon atoms. Using those ex-
periments allows establishing connectivity between the resonances of two adjacent residues
in the sequence. For example, CBCA(CO)NH connects an amide group with Cα and Cβ
of the preceding residue (Fig. 3.5A, left) and HNCACB connects an amide group with Cα
and Cβ of both this residue as well as the preceding one [342] (Fig. 3.5A, right). Using
these experiments, resonances for 1H, 15N and 13C for the backbone (Cα and amide group)
as well as side chain Cβ can be assigned to a particular protein residue. An example is
shown in Figure 3.5B for a short segment of Endophilin SH3. With the presence of signal
at the same 13C chemical shift in both HNCACB of one residue and CBCA(CO)NH of the
preceding residue, a link can be established between the two residues. This information,
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Figure 3.5: A. Magnetisation transfer in CBCA(CO)NH (left) and HNCACB (right)
spectra. B. Assignment of a fragment of Endophilin SH3 using CBCA(CO)NH (green)
and HNCACB (red for Cα and blue for Cβ)
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Figure 3.6: Assigned 1H-15N HSQC of Endophilin SH3 free (red) or with increasing
amounts of Alix (yellow, blue). Blue and pink circles indicate residues with clear interme-
diate exchange rate.
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together with the Cα and Cβ chemical shift values characteristic for each amino acid types
allows identification of each spot and unambiguous assignment for the backbone resonances
of a protein.
After complete assignment of SH3 resonances, CSP data for Endophilin SH3 obtained
after addition of increasing amounts of Alix can be quantified and assigned to a particular
residue (Fig. 3.6). Assignments are shown in black for backbone N-H and green for Asn
and Gln side chain N-H. SH3-Alix shows evidence of intermediate exchange rate on the
NMR timescale. This can be seen by the broadening of a single peak at intermediate
concentrations (see E304, pink circle in Fig. 3.6) resulting in a reduction of peak intensity,
in the case of E304 below the set intensity threshold. Intermediate exchange rate can
also be deduced from the presence of two resolved peaks at an intermediate frequency
(see E345 or E306, blue circles in Fig. 3.6). This contrasts with slow exchange (tighter
binding), where two environments would be seen at the same frequencies of free and bound
states or fast exchange (weaker binding), where only one peak at an intermediate frequency
weighted according to the relative population of free and bound states would be seen.
The strength of a CSP can be quantified in both 1H and 15N directions and is then combined
into a weighted CSP as described in Material & Methods (chapter 5). The resulting shift
map of CSP plotted along the SH3 sequence (Fig. 3.7A) was similar to what was reported
for Endophilin SH3  Synaptojanin PRD or Parkin Ubl complexes [229] and together with
the heatmaps of CSP intensities on the structure of Endophilin suggest that Alix binds
in the canonical SH3 peptide binding groove (Fig. 3.7B). Repeating the same experiment
but using 1H-13C HSQC revealed five additional residues with high CSP (L298, D300,
P303, N305 and Q322) and confirmed that the canonical SH3 peptide binding groove is
the interaction surface with Alix (Fig. 3.7C). No evidence of Alix peptide wrapping around
the SH3 and making additional contacts could be seen in either of the spectra as in both,
the interaction surface seemed restricted to the canonical one (Fig. 3.7B, C).
The process was then repeated for 13C/15N-labelled Alix with unlabelled SH3. After as-
signment of Alix resonances, 1H-15N HSQC spectra were recorded in the absence (red) or
with saturating concentrations (blue) of Endophilin SH3 (Fig. 3.8A). Chemical shifts for
residues R14 and V19 as well as L20, N23 and R24 (blue circles in Fig. 3.8A) were heavily
perturbed after addition of SH3. An HSQC recorded for an intermediate concentration of
SH3 (not shown) did not show peaks at an intermediate chemical shift but produced severe
line broadening. A heatmap of Alix coloured according to the intensity of CSP indicates
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Figure 3.7: Endophilin SH3 CSP upon Alix titration. A. Shift map of CSP derived
from 1H-15N HSQC. P indicate proline residue for which no information is available. B.
Corresponding SH3 heatmap. C. Heatmap of CSP derived from 1H-13C HSQC. Yellow is
unaffected, red is highly perturbed. The middle figure shows the canonical SH3 binding
surface, figures on the left and right are rotated by 120◦.
that the binding motif is between residues A13 and A25, as residues outside of this region
were barely perturbed upon titration of SH3 (Fig. 3.8B). Interestingly, resonances for some
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residues like S3, W4, T7 or K8 as well as side chains amine were split (Fig. 3.8A, pink
circles), an effect that was most strongly marked close to P6.
Figure 3.8: Titration of Endophilin SH3 on Alix, effects on 1H-15N. A. 1H-15N HSQC
of Alix free (red) or with saturating amounts of Endophilin SH3 (blue). B. Heatmap of
Alix shown in a PPII helix conformation and coloured according to CSP upon Endophilin
SH3 titration and corresponding sequence. Yellow is unaffected, red is highly perturbed,
prolines are in grey.
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Figure 3.9: Titration of Endophilin SH3 on Alix, effects on 1H-13C. A. Methyl group
region of 1H-13C HSQC of Alix free (red) or with saturating amounts of Endophilin SH3
(blue). B. Cα/Hα region of the same spectra. C. Heatmap of Alix coloured according
to CSP of Cα/Hα upon Endophilin SH3 titration and corresponding sequence. Yellow is
unaffected, red is highly perturbed, grey indicates residues for which no information was
obtained due to peak overlap.
This could be due to a very slow proline cis-trans isomerisation, creating different chemical
environments for residues ahead of it.
CSP measured in 1H-15N HSQC after titration of Endophilin SH3 on Alix gave indications
about the putative binding site (Fig. 3.8). However, Alix is composed of a high number
of proline residues (12 of the 28 amino acids are proline), for which no information can be
obtained in a 1H-15N HSQC spectrum due to the absence of backbone N-H in a proline
residue (Fig. 3.8B, grey). In order to gain information from prolines as well as side chains,
the titration experiment was also assessed by collecting 1H-13C HSQC spectra (Fig. 3.9).
Two regions of the spectra overlays are shown. In the methyl region (Fig. 3.9A), similarly
to what was observed in 1H-15N HSQC, both V19 and L20 were highly perturbed. In the
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Cα/Hα region, in addition to residues identified in the 1H-15N HSQC (Fig. 3.8A), Q10 and
A22 also displayed CSP (Fig. 3.9B, blue circles). A heatmap coloured according to the
intensity of CSP for Cα/Hα shows that residues Q10 to A22 are perturbed, in particular
R14, V19 and L20 (Fig. 3.9C).
Distance restraints for SH3-Alix complex
Although CSP analysis narrowed down the binding site on Alix, more data were needed to
characterise it precisely. 1H-1H NOESY (Nuclear Overhauser Effect Spectroscopy) spectra
provide valuable information for intermolecular interactions. A 1H-1H NOESY spectrum
correlates resonances of protons which are in close distance from each other through space
(less than 5Å), without the need for a covalent link. Using this NMR experiment, close
proximity of Alix protons with SH3 protons can be detected. Isotope filtered NOE spectra
were acquired to record only NOEs between 13C-labelled SH3 and unlabelled peptide. Un-
fortunately, no usable NOEs were recorded as is commonly the case for protein complexes
stabilised largely by electrostatic interactions. So another strategy to obtain distance re-
straints was tried. Paramagnetic probes (nitroxide radicals, Mn2+, lanthanides) possess
an unpaired electron and can be used to determine long-range distance restraints (up to
20-30Å). Unpaired electrons in proximity provide additional relaxation mechanisms, re-
sulting in line broadening, called PRE (paramagnetic relaxation enhancement) [340]. As
consequence of line broadening, a reduction in peak intensity is observed in the HSQC
spectra, indicating proximity to the PRE probe.
To find out the orientation in which Alix binds and differentiate between class I and class
II binding as well as obtain some distance restraints, PRE were mapped onto Endophilin
SH3 after addition of Alix labelled with 4-maleimido-TEMPO (2,2,6,6-Tetramethyl-1-
piperidinyloxy), a PRE probe with a nitroxide radical (Fig. 3.10), at different positions
along its sequence. For this, Alix residues T7, P17 and A25 were individually mutated
to cysteine and labelled with TEMPO. 1H-15N HSQC spectra of SH3 were then recorded.
Reduction in SH3 peak height (PRE) in the presence of TEMPO-labelled Alix is reported
along the SH3 sequence (Fig. 3.11A). Mapping the PRE on the SH3 structure (Fig. 3.11B)
indicates that Alix is a class II binder, binding N -> C when facing the binding pocket.
This can be deduced from the fact that with TEMPO labels closer to Alix C-terminus, the
right part of the SH3 is more affected by PRE than the left side (when facing the binding
pocket) (Fig. 3.11B).
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Figure 3.10: Nitroxide radical probe 4-maleimido-TEMPO (2,2,6,6-Tetramethyl-1-
piperidinyloxy)
Figure 3.11: Shift maps (A) and heatmaps (B) of Endophilin SH3 PRE induced by
TEMPO-labelled Alix at positions T7 (left), P17 (middle) or A25 (right). Yellow is unaf-
fected, red is highly perturbed.
SH3-Alix model
Using CSP and PRE experiments, a binding site of Endophilin on Alix was narrowed down
and the orientation of binding determined. While this does not resolve all possible ambi-
guities of potential binding modes, the information can be used as an input for a docking
software that should be able to resolve the energetically most favoured state. HADDOCK
(High Ambiguity Driven biomolecular DOCKing) software models the preferred orienta-
tion of two molecules relative to each other using ambiguous interaction restraints (AIRs)
to drive the docking process [343, 344]. An AIR corresponds to an intermolecular distance
shorter than a set threshold between any atom of an active residue of the first protein to
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any atom of any residue of the second protein. When using CSP data, a residue is consid-
ered active for HADDOCK if it both displays CSP above a certain threshold and has high
solvent accessibility at the surface in the free protein. Residues in the core of the protein
that display CSP because of a conformational change upon binding will not be used to
drive the contact surface. HADDOCK performs rigid body fit between structures of both
proteins while the residues at the interface are kept flexible to optimise interface packing.
Structures are then ranked by intermolecular energy which comprises electrostatic, van der
Waals, solvation and AIR energies [343].
Active residues for SH3 and Alix were defined according to the previously obtained CSP
and PRE data (residues 299, 302, 304, 306, 307, 323, 324, 325, 326, 338, 342, 343 for SH3
and 13, 14, 19, 20, 21, 22, 23, 24 for Alix). In the first modelling rounds, an unbiased
approach where the structure of Alix was not presupposed, was tried, but no convergence
of models was reached. In the next step, modelling with preformed Alix was tried. Alix
was either flexible or forming a α-helix, a β-sheet or a polyproline II (PPII) helix. Best
models were obtained with Alix in a PPII helix conformation. This is also consistent with
the literature, as canonically, SH3 domains bind consensus PxxP peptides in a PPII helix
conformation [324, 322]. From then on, all modelling was performed with peptides in a
PPII helix conformation. As the initial simulations failed to converge upon a single model
with low energy, unambiguous restraints were applied to bias the model in order to eval-
uate different registers of the peptide within the SH3 binding groove, in both class I and
class II binding. All possible permutations of PxxP occupancy were explored for ALIX.
The residue in a subsite was restrained to within 7 Å of the following SH3 residues:
P3 site: Y299, D300, Y343
P2 site: Y299, N342, Y343
P0 site: F301, W327, P340, Y343
P-1 site: N326, W327, P340
Models with lowest HADDOCK score (corresponding to EVanderWaals + 1/5 Eelectrostatics +
Edesolvation) and consistent with PRE data were preferred. However, binding energies cal-
culated by HADDOCK did not identify one binding mode as having a uniquely strong
affinity, and several registers of Alix in the SH3 binding groove had similar docking score
(Tab. 3.2).
In the best model obtained for Alix (PaRP), Endophilin binding site was identified as
KPQPPARPPP (Fig. 3.12, left). PaRP is in the binding pocket (Fig. 3.12A), with R14
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Table 3.2: Summary of HADDOCK results for the two best SH3-Alix models
Parameter PARP PPPV
HADDOCK Score -66.9±0.7 -61.3±3.5
Cluster Size (out of 200 calculated structures) 200 200
RMSD from reference structure (Å) 2.1±1.3 2.1±1.3
EVanderWaals (kcal/mol) -49.1±2.8 -45.4±5.6
Eelectrostatics (kcal/mol) -145.0±10.8 -79.5±34.8
Edesolvation (kcal/mol) -2.1±0.9 -3.5±2.6
Buried Surface Area (Å) 1205.3±22.1 1240.2±27.4
side chain forming salt bridges with side chains of E304 and E308 (Fig. 3.12B). The compass
pocket is occupied by a proline residue (P17) stacking against SH3 W327 (Fig. 3.12B). This
model is also consistent with PRE data, placing T7 far on the left of the SH3, P17 close,
on the right side of the binding groove and A25 further right (when facing the binding
site on the SH3). However, the preferred model cannot on its own explain all of the data
collected. In the titration experiment with SH3 on Alix (Fig. 3.8, 3.9), important CSP
were observed for R14, V19 and L20. In the current model where PaRP is in the binding
site (Fig. 3.12C), high CSP for R14 are easily explained as R14 sits in the binding site
in close proximity of the SH3. However, V19 and L20 are further away from the SH3
(Fig. 3.12C) and their chemical environment should not be that heavily perturbed upon
addition of SH3. Alix CSP data are more compatible with the second best HADDOCK
model, in which RPPPPVLPA sits on the SH3 binding pocket (Fig. 3.12, right).
In this model, PpPV is in the center of the binding site, P15 is situated in a hydrophobic
pocket formed by the conserved Y299 and Y343 and the hydrophobic compass pocket
formed by W327 and F338 is occupied by P21-A22 (Fig. 3.12E,F). Although this model
explains CSP data for Alix well (Fig. 3.12G), it is less compatible with PRE data obtained
with TEMPO-labelled Alix at different positions (Fig. 3.11). In particular, P17 labelled
with TEMPO gives rise to PRE mostly on the right side of the SH3 (Fig. 3.11B). For a class
II binder, this means that P17 is C-terminal of the binding motif. However in rppPpvlp,
P17 is N-terminal and part of PpPV.
NMR experiments followed by modelling proposed two models which are each compatible
with most but not all data collected. In order to test the importance for SH3-Alix complex
formation of some key residues identified, these amino acids from Alix were mutated to
alanine. The effect of these mutations was evaluated by pulling down Endophilin full-length
or Endophilin SH3 from bacterial lysate overexpressing these constructs with GST-tagged
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Figure 3.12: Models of SH3-Alix complex with KPQPPARPPP (left) or RPPPPVLPA
(right) binding motifs. A, E. Surface representation of SH3 in SH3-Alix complex. B, F.
Detail of binding site with residues providing specificity shown in sticks colours. C, G.
Overview of CSP fitting (green) the model or not (red). D, H. Overview of PRE fitting
(green) the model or not (red).
Alix mutants (Fig. 3.13). R14 and L20 were identified in CSP analysis as being heavily
perturbed (Fig. 3.8) and mutation to alanine prevented Endophilin pull-down (Fig. 3.13).
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V19 also showed important CSP, however mutating it to alanine did not affect the SH3-
Alix complex (Fig. 3.13). This can be explained by the fact that, in the PpPV model
(Fig. 3.12E), V19 sits at the top of the prism formed by a PPII helix and its side chain
points away from the SH3 or in the PaRP it would be far enough from the SH3. Although
chemical shifts for those residues were little affected upon SH3 addition, mutating the
pair P9/P12 to alanine prevented pull-down of Endophilin SH3 but not of the full-length
protein (Fig. 3.13). Similarly after mutating the pair P18/P21 to alanine, GST-Alix could
not pull-down Endophilin SH3 but pull-down of the full-length protein was not affected
(Fig. 3.13). This could be due to disruption of the PPII fold upon mutation of these
prolines. Pull-down experiments with Alix mutants did not help distinguishing between
both proposed models of SH3-Alix complex and further experiments will be needed.
Figure 3.13: Pull-down of Endophilin full-length (Endo) or SH3 with GST-Alix mutants.
Effect on mutation to alanine is indicated in Alix sequence (red corresponds to no binding,
orange to reduced binding and green to unaffected binding).
3.2.3 Endophilin A1 SH3 - ADRA2A ICL3 interaction
SH3-ADRA2A model
Using Alix as a test candidate, its Endophilin binding site could be mapped and a strategy
to identify it using NMR was developed. After quantifying ADRA2A fragment affinity
for Endophilin SH3 by ITC, structural characterisation of its Endophilin binding site was
carried out following the strategy developed for Alix. First ADRA2A was titrated on SH3
to confirm the interaction surface on Endophilin SH3 by measuring CSP (Fig. 3.14). The
observed CSP (Fig. 3.14A) plotted onto the SH3 sequence (Fig. 3.14B) were very similar
to what was observed for Alix and, together with a heatmap of SH3 coloured according
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to CSP, confirmed that binding of ADRA2A by Endophilin SH3 occurred in the canonical
SH3 binding pocket (Fig. 3.14C).
Figure 3.14: Endophilin SH3 CSP upon ADRA2A titration. A. 1H-15N HSQC of En-
dophilin SH3 free (red) or with increasing amounts of ADRA2A (yellow, blue). B. Shift
map of CSP derived from 1H-15N HSQC for Endophilin SH3 in complex with ADRA2A
(red) compared to those obtained with Alix (black), P indicate proline residue for which
no information is available. C. Corresponding SH3 heatmap
After assignment of ADRA2A resonances, the binding site on ADRA2A was further de-
limited by titrating SH3 onto ADRA2A and recording CSP (Fig. 3.15A, resonances shift
between free ADRA2A in red, ADRA2A-SH3 complex in blue). In addition, PRE were
recorded on ADRA2A after addition of SH3-E304C-TEMPO. E304 residue lies at the top
of the RT loop, above the center of the binding site (Fig. 3.16). Weaker peak intensity be-
fore (Fig. 3.15B, pink) compared to after TEMPO reduction (Fig. 3.15B, black) indicates
NH protons in proximity of SH3 E304 and therefore of the binding site. For example, G19
(circled in pink) both displays CSP as seen by a shift between its free and complex form
(Fig. 3.15A) as well as PRE (Fig. 3.15B). This indicates that G19 is in the binding site
as it is close to the SH3 and to E304. H13 (circled in blue), on the other hand, is close
to the SH3 but away from E304 and therefore away from the binding site, as H13 only
shows CSP but no PRE (Fig. 3.15A,B). Combining both CSP and PRE data sets delimits
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Figure 3.15: CSP and PRE of ADRA2A with Endophilin SH3. A. 1H-15N HSQC of
ADRA2A free (red) or with increasing amounts of Endophilin SH3 (yellow, blue). B. 1H-
15N HSQC of PRE on ADRA2A in the presence of SH3-E304C-TEMPO before (pink) and
after (black) TEMPO reduction. C. Corresponding heatmap of ADRA2A shown in a PPII
helix conformation. CSP are coloured yellow (no perturbation) to red (highly perturbed).
Residues in purple show high PRE. Prolines are in dark grey and residues for which no
assignment was available are in light grey.
the binding site (Fig. 3.15C) between residues H13 and G26 as residues outside of this
sequence remain unaffected by SH3 titration or presence of a paramagnetic probe on top
of the binding site.
Similarly to what has been previously done with Alix, ADRA2A was labelled at different
sites with TEMPO in order to determine its orientation on SH3. PRE were recorded on
SH3 in complex with ADRA2A labelled at D12 or E24 (Fig. 3.17). Labelling ADRA2A
N-terminally of the previously identified binding site (D12) mostly affected residues on the
left side of the SH3 (Fig. 3.17A), whereas a TEMPO-label on E24, C-terminally of the
binding site, induced PRE on the right side of the SH3 (Fig. 3.17B). This data suggest
that ADRA2A, like Alix, is a class II binder oriented N -> C.
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Figure 3.16: Position of E304 on Endophilin SH3 for TEMPO labelling. E304 is in red
and residues lining the binding groove in sticks and darker blue.
HADDOCK modelling was then carried out with CSP and PRE similarly to Alix with
ADRA2A prefolded in a PPII helix. SH3 residues 299, 326, 327, 338, 342, 348 and
ADRA2A residues 13-26 were defined as active. As for Alix, no convergence into a single
model was reached in the initial simulations, so unambiguous restraints were applied to
evaluate all possible permutations of PxxP occupancy, in both class I and class II bind-
ing, for ADRA2A on the SH3. To achieve this, residues were restrained within 2Å of the
residues forming each subsite (P3, P2, P1 and P-1) on the SH3. Two models with similar
HADDOCK scores were obtained (Tab. 3.2).
Table 3.3: Summary of HADDOCK results for the two best SH3-ADRA2A models
Parameter PPGP PRRP
HADDOCK Score -57.5±2.4 -54.0±1.7
Cluster Size (out of 200 calculated structures) 200 200
RMSD from reference structure (Å) 1.9±2.0 0.8±0.5
EvanderWaals (kcal/mol) -42.3±1.3 -43.4±2.1
Eelectrostatics (kcal/mol) -136.1±31.5 -127.9±13.8
Edesolvation (kcal/mol) 4.4±7.5 0.2±0.9
Buried Surface Area (Å) 1085.5±68.9 1009.8±31.7
In the best model, HAERPPGPRR was identified as the ADRA2A binding motif on En-
dophilin SH3 (Fig. 3.18A). PpGP is in the binding pocket and contacts are formed between
R16 side chain and D300 main chain carbonyl, R21 and E304 side chains, as well as R22
side chain with both backbone and side chain carbonyl groups of E306 (Fig. 3.18B). An
additional contact is formed from R22 backbone amide to the side chain carbonyl of E308
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Figure 3.17: Shift maps (A) and heatmaps (B) of Endophilin SH3 PRE induced by
TEMPO-labelled ADRA2A at positions D12 (left) or E24 (right). Yellow is unaffected,
red is highly perturbed.
(Fig. 3.18B). This model gave slightly higher HADDOCK scores and was better compati-
ble with PRE data, however, a different model could not be excluded. In this alternative
model with RPPGPRRPER as ADRA2A binding motif, PrRP was in the binding pocket
(Fig. 3.18C), with R22 forming a salt bridge with SH3 E308. R25 is located in the compass
pocket and also forms salt bridges with the backbone carbonyl and the side chain of SH3
E306 (Fig. 3.18D).
Phosphoregulation of SH3  ADRA2A
After short agonist stimulation, ADRA2A is rapidly desensitised by phosphorylation of
its ICL3 by GRK3 (G protein-coupled receptor kinase 3) [345, 346, 347]. The phospho-
rylation site was identified as a stretch of four serines preceded by two glutamates [348].
Following agonist exposure, PKC (protein kinase C) was also shown to phosphorylate
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Figure 3.18: Model of SH3-ADRA2A complex with HAERPPGPRR (left) or RPPG-
PRRPER (right) binding motif. A,C. Surface representation of SH3. B,D. Detail of binding
site with residues providing specificity shown in sticks.
ADRA2A ICL3 at S360 [349], resulting in receptor desensitisation. According to Phos-
phoSitePlus [www.phosphosite.org], other phosphorylation sites have been identified by
mass spectrometry on S324, S331 and T344, for the phophorylated residues in the ICL3
fragments used here (Fig. 3.19A). To check if phosphorylation could have a role in FEME
of ADRA2A, some of those residues were mutated to aspartate or glutamate to imitate a
phophorylated serine. Then binding was assessed by pull-down experiments with GST-SH3
and His-SUMO-tagged peptides after tag cleavage (Fig. 3.19B). Whereas neither S43E nor
S72D mutations affected pull-down efficiency of ADRA2A(293-374) by Endophilin SH3,
mutation of the four serines SSSS(8-11)DDDD abolished pull-down by Endophilin SH3
in the shorter construct ADRA2A(293-339) only. This was further confirmed by ITC
measurements (Fig. 3.19C). Affinity for Endophilin SH3 to ADRA2A ICL3 wild-type was
13µM (Fig. 3.3B), but was reduced to 63µM for ADRA2A SSSS(8-11)DDDD mutation,
indicating an effect on Endophilin binding. This was surprising as in titration experiments
(CSP) of SH3 on ADRA2A, there was no indication that those residues were in proximity
of the SH3 (Fig. 3.15). A precise mechanism on the effect of phosphorylation by GRK3
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on binding of ADRA2A to Endophilin SH3 is still lacking, although it is likely due to a
general electrostatic repulsion.
Figure 3.19: Effect of ADRA2A phosphomimetics on Endophilin binding. A. Identified
phosphorylation sites in ADRA2A ICL3 (black). Mutations tested here are indicated for
the longer (dark blue) and shorter (blue) constructs with numeration according to the
NMR construct (blue). Mutations negatively affecting the binding to Endophilin SH3
are indicated in red, mutations with little effect are in green. B. Pull-down by GST-
Endophilin SH3 of ADRA2A phosphomimetics mutants on ADRA2A(293-374) (top) or
ADRA2A(293-339) (bottom). C. ITC measurement of affinity between Endophilin SH3
and ADRA2A(293-339) SSSS(8-11)DDDD. Top: released heat, bottom: binding enthalpy.
3.3 Discussion
Endocytosis is essential for a cell to take up nutrients, regulate the plasma membrane sur-
face area as well as the concentration of receptors on the cell surface. In addition to its
multiple roles in clathrin-mediated endocytosis, Endophilin is also an essential component
of a clathrin-independent endocytosis route, FEME (fast Endophilin-mediated endocyto-
sis), in which it binds cargo directly or through adaptor proteins using its SH3 domain
[120]. However, despite experiments based on peptide libraries and modelling [335, 336],
no consensus sequence for Endophilin SH3 binding was determined. Here, I characterised
the binding of Endophilin SH3 to a cargo (ADRA2A) and an adaptor protein (Alix) us-
ing pull-downs and measured the affinity of interactions by ITC. We confirmed that both
peptides bind Endophilin SH3 in the canonical binding groove. Endophilin binding site
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was then mapped on two of these peptides, ADRA2A ICL3 and Alix PRD, by NMR using
a strategy combining CSP (chemical shift perturbations), PRE (paramagnetic relaxation
enhancement) and modelling.
Endophilin SH3 and Alix PRD fragment offered an ideal system for structure determina-
tion by NMR, given their small size and the good spread of resonances for Endophilin SH3
(Fig. 3.4). However, the high number of proline residues in Alix (12 out of 28 amino acids),
most of them concentrated around the putative binding site, complicated the process. Sev-
eral prolines were in a similar chemical environment and therefore showed similar chemical
shifts. With overlapping peaks (Fig. 3.9A), these residues could not be distinguished from
each other. Critical information was therefore missing or not usable as these residues were
in the proximity of the identified binding site.
A powerful NMR experiment for structure determination consists in measuring NOEs (Nu-
clear Overhauser Effect) between two protons. In our case, intermolecular NOEs between
SH3 and Alix protons would be most relevant and provide distance restraints, as presence
of an NOE indicates a distance of less than 5Å between the two corresponding atoms. To
constrain a structure such as SH3-Alix complex, even fewer than 10-20 NOEs would greatly
assist in distinguishing between alternative binding modes. However, no NOEs could be
observed experimentally. This has also been reported for other SH3-peptide complexes
[350, 351]. The alternative approach we used consisted in collecting PRE data with the
nitroxide radical TEMPO. Proximity to the radical, within 20-30Å, results in peak broad-
ening. Labelling Alix or ADRA2A peptides at different positions along their sequence and
observing PRE on Endophilin SH3 resonances revealed that these peptides are class II
binders, binding N -> C when facing the binding pocket (Fig. 3.11, 3.17).
Although HADDOCK-based modelling of SH3-peptide complexes based on CSP data only
has been successful [350, 351], in the case of SH3-Alix, CSP and PRE data were not enough
for an unbiased model to converge into one most favoured conformation. However, with
the additional information that SH3 generally bind peptides in a polyproline II (PPII)
helix conformation, all possible permutations of PxxP on the SH3, in both class I and class
II, could be evaluated. For Alix, two putative binding sites were compatible with most but
not all CSP and PRE data. The first model with PaRP in the binding site (Fig. 3.12A)
is most consistent with PRE data, it however does not explain the high CSP observed for
V19 and L20 both for the backbone and the side chains as in this model, these residues
would be further away from the SH3 (Fig. 3.12C). In the second model, V19 and L20 are
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in the binding site (occupied by PpPV), which explains very well the high CSP observed
(Fig. 3.12E). However, PRE data situate T7 N-terminally and P17 and A25 C-terminally of
the binding motif, which is incompatible with 15-PPPV-19 in the binding site (Fig. 3.11H).
An attractive hypothesis that could explain why two Endophilin binding sites were identi-
fied for Alix is that both coexist and Endophilin SH3 can bind either with similar affinities
(explaining why only one transition was observed by ITC). Binding of Alix to Endophilin
SH3 occurs in a 1:1 manner as measured by ITC, however, as Endophilin dimerises via
its BAR domain, close proximity of both SH3 domains in Endophilin full-length might
provide avidity and both SH3 might bind, one on the PaRP site and the other on PpPV.
Synaptojanin, another Endophilin binding partner [240], also shares similar features where
Endophilin binding site is formed of two PxxP motifs separated by two residues. A double
PxxP motif might be a common feature for tight Endophilin binders given its dimeric
nature. Pull-down of Endophilin full-length or SH3 domain were differently affected by
mutations in Alix (Fig. 3.13), also supporting the idea that Endophilin full-length offers
additional binding modes compared with SH3 only. Further experiments will be necessary
to elucidate mechanistic details of Endophilin  Alix binding and probe the two-binding
sites hypothesis.
Titration of SH3 on ADRA2A ICL3 fragment resulted in narrowing the binding site to
residues A14-E24 (Fig. 3.15). This explains why mutating R21 and R22 to alanine resulted
in a decreased pull-down efficiency (Tab. 3.1) as, according to the model obtained, those
residues are located in the middle of the binding pocket (Fig. 3.18). Interestingly, R46 and
R47 were also identified as residues contributing to binding to Endophilin as mutating them
to alanine also prevented efficient pull-down (Tab. 3.1). There was however no indication
of proximity of those residues to Endophilin SH3 as their resonances remained completely
unaffected by the presence of SH3 (Fig. 3.15). The effect of the phosphomimetics mutations
SSSS(8-11)DDDD resulting in a reduced affinity to Endophilin SH3, as observed both
by pull-down and ITC (Fig. 3.19), cannot be explained by the current model, as these
residues are positioned further away from the SH3 (Fig. 3.18) and their resonances were not
perturbed after addition of SH3 (Fig. 3.15). The importance of these observations should
be tested in vivo. After confirming that uptake of stimulated ADRA2A is Endophilin-
dependent and occurs through the FEME pathway, the importance of the binding site
identified here for ADRA2A endocytosis would be confirmed by mutating key residues. The
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effect of phosphorylation on ADRA2A uptake could then be probed with phosphomimetics
mutants.
Few SH3  peptide interactions were observed in any of the models. In Alix PaRP as well
as ADRA2A PrRP (Fig. 3.12A, 3.18C), an arginine is in the center of the binding pocket
and contacts glutamate side chains on the SH3, whereas in Alix PpPV (Fig. 3.12E), a
hydrophobic amino acid or, in ADRA2A PpGP, a glycine, is situated there (Fig. 3.18A).
The compass pocket is occupied by a hydrophobic amino acid, either a proline stacking
against an SH3 tryptophan in the case of Alix PaRP or by an alanine residue for Alix PpPV
(Fig. 3.12B, 3.12F), whereas in ADRA2A PrRP, an arginine is situated there and makes
additional contacts with backbone and side chain of an SH3 glutamate(Fig. 3.18B) or in
PpPG an arginine backbone sith there. In addition, in Alix PpPV model, a hydrophobic
pocket on the other side of the binding site is also occupied by a hydrophobic amino acid
(Fig. 3.12F). In none of the cases there is indication of the peptide wrapping around or
forming any contact outside of the canonical binding groove. This raises the question
on the specificity of Endophilin recognition of its targets. PxRP or PxφP (φ indicates a
hydrophobic residue) followed by either arginine or a hydrophobic residue are very common
motifs and might not be enough to explain Endophilin SH3 preference for those sequences
over other similar ones.
The identified Alix PaRP and ADRA2A PrRP binding sites show interesting sequence
similarities, which are also shared with the PP19 peptide of synaptojanin used to prevent
Endophilin  synaptojanin interactions that result in CME defects [240] and a peptide from
Itch ubiquitin ligase [336]. An alignment of the sequences (Fig. 3.20) shows a consensus
+PxxPxRP (+ indicating a conserved basic residue). Although this consensus does not
take into account the other binding site for Alix (PpPV) or ADRA2A (PpPG), search
through protein databases was conducted with this consensus sequence and resulted in
identification of several cell surface receptors as putative Endophilin targets. It is worth
noting though that this sequence is not sufficient to explain all the receptors  SH3 interac-
tions reported by Boucrot et al. [120], so this consensus sequence might be too restrictive.
Nevertheless, future experiments will be carried out with the receptors identified in the
database search, testing for in vitro interaction with Endophilin SH3 and so verifying the
postulated Endophilin consensus sequence.
Here, we characterised the binding of Endophilin SH3 to two of its targets, a cargo cell
surface receptor and a cargo adaptor protein. Using an approach combining NMR chemical
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Figure 3.20: Alignment of Endophilin binding motifs in Alix, ADRA2A, Itch and synap-
tojanin and resulting consensus sequence.
shift perturbations and paramagnetic relaxation enhancement experiments together with
modelling, we identified the Endophilin binding site on ADRA2A and described two pu-
tative sites on Alix. I also showed that, in addition to its role in receptor desensitisation,
phosphorylation of ADRA2A might also play a role in its Endophilin-mediated uptake.
These results confer further insights in the cargo selection step of the FEME pathway and
open up the way for identification of additional FEME cargo.
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Chapter 4
Final thoughts
In this thesis, I established a new assay, NTA, to study membrane curvature sensitivity of
proteins. In a screen of non-BAR lipid-binding domains, I could identify AKT PH domain
as a new curvature sensor. During the screen, a key factor was the careful choice of exper-
imental conditions, protein and lipid concentrations and especially lipid composition, in
order to observe binding. This reinforces the concept that membrane binding is a complex,
fine-tuned process of weak and lipid-specific interactions. It also suggests that there might
be non-described lipid-binding domains that bind weakly and cannot be observed with
current standard methods and experimental conditions.
Identification of AKT PH domain as a curvature sensor lacking both amphipathic helix and
BAR domain raises the question of alternative mechanisms to sense membrane curvature.
Although curvature sensing by amphipathic helix insertion or BAR domain scaffolding has
been extensively studied, molecular mechanistic details are not completely understood.
Similarly, the relationship between curvature sensing and generation is unclear: are they
two faces of the same coin or different processes? NTA might help shed light on some
of these questions by identifying further curvature sensors or, for example, by helping to
understand the contributions to curvature sensing by the BAR domain or the amphipathic
H0 helix of Endophilin.
Endophilin is a key effector of FEME pathway, however the molecular basis of cargo selec-
tion and how the curvature generation properties of Endophilin contribute to the pathway
remain unknown. In this thesis, I investigated Endophilin binding to cargo by modelling
the binding of its SH3 domain to two peptides using NMR data. A putative consensus
sequence could be identified and will be confirmed. The differences in interactions between
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Endophilin SH3 and each of the two peptides suggests that binding is more complex. As
new modes of binding SH3 and consensus sequences are published, the view increasingly
diverges from the canonical model of SH3 binding to a PxxP motif to a complex collection
of several weak interactions.
Endophilin is a particularly interesting protein that encompasses both an N-BAR domain
responsible for curvature sensing and generation as well as an SH3 domain binding cargo.
This suggests that Endophilin might be responsible for each step of the FEME pathway.
It however raises the question of how a small protein can do it all and which are the
requirements for molecular arrangements.
In recent years, theoretical and practical technologies have significantly improved. With
increasing computer power and algorithms, simulations can be performed on longer time
scales or with increasing molecular resolution. Cryo-EM allows structural characterisation
of proteins and their relationship with the membrane at atomic resolution. The range
of biophysical techniques has expanded, facilitating the study of protein-membrane inter-
actions in multiple ways under different conditions and single-molecule techniques have
become more robust and easy to use. The curvature field can benefit from all these devel-
opments. Exciting times lie ahead.
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Chapter 5
Material and methods
5.1 Reagents
5.1.1 Buffer recipes
Table 5.1: Buffer recipes used in this thesis
Buffer name Acronym Buffer composition
Protein purification
IMAC lysis buffer IMAC-L
20mM Tris pH 8.0, 200mM NaCl, 50mM
imidazole, 0.5mM TCEP, EDTA-free
protease inhibitors
IMAC wash buffer IMAC-W
20mM Tris pH 8.0, 200mM NaCl, 50mM
imidazole, 0.5mM TCEP
IMAC elution buffer IMAC-E
20mM Tris pH 8.0, 200mM NaCl, 250mM
imidazole, 0.5mM TCEP
Anion exchange buffer A IEX-A 20mM Tris pH 8.0, 0.5mM TCEP
Anion exchange buffer B IEX-B
20mM Tris pH 8.0, 500mM NaCl, 0.5mM
TCEP
Continued on next page
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Table 5.1  Continued from previous page
Buffer name Acronym Buffer composition
Cation exchange buffer A IEX2-A 20mM HEPES pH 7.4, 0.5mM TCEP
Cation exchange buffer B IEX2-B
20mM HEPES pH 7.4, 500mM NaCl,
0.5mM TCEP
Size exclusion buffer GEF
20mM HEPES pH 7.4, 150mM NaCl,
0.5mM TCEP
Assay buffers
Pull-down wash buffer PD
20mM HEPES pH 7.4, 150mM NaCl, 1mM
EDTA, 0.1% Triton X-100
NanoSight buffer NS 20mM HEPES pH 7.4, 100mM NaCl
NMR buffer NMR
20mM HEPES pH 7.4, 100mM NaCl,
0.5mM TCEP
Bacterial culture
Transformation buffer TF 100mM CaCl2
2xTY medium 2xTY
16 g/l Bactotryptone, 10 g/l yeast extract,
5 g/l NaCl
M9- minimal medium M9-
41mM Na2HPO4, 22mM KH2PO4, 8.55mM
NaCl, 2mM MgS4, 0.1mM CaCl2
100x metal mix MM
13.4mM EDTA, 3.1mM FeCl3,
620µM ZnCl2, 76µM CuCl2, 42µM CoCl2,
162µM H3BO3, 8.1µM MnCl2
100
5.1.2 Liposome preparation
Lipid stocks in chloroform were mixed in a glass vial. Lipids used can be found in table
5.2. The solution was evaporated against the walls of the vial using an argon stream.
The dried lipid film was then placed for 30min in a dessicator to completely evaporate
remaining organic solvents and water. For long-term storage, the vial was filled with argon
gas and stored at -20 ◦C.
Lipids were resuspended at a concentration of 0.5mg/ml in NS buffer by rolling for 2 h
at room temperature. The solution was vortexed twice for 20 s each during those 2 h.
Liposomes were extruded using 800 nm, 200 nm, 100 nm and 50 nm Whatman Nucleopore
Polycarbonate filters in an Avanti Mini Extruder. Fresh liposomes were kept at room
temperature and used within 24 h.
Table 5.2: Lipids used in this thesis
Lipid Origin Acronym Company
Brain Polar Lipid Extract Porcine brain FolchA Avanti Polar Lipids
Brain Extract, Type I Bovine brain FolchS Sigma-Aldrich
2-Oleoyl-1-palmitoyl-sn-
glycero-3-phosphocholine
Synthetic POPC Sigma-Aldrich
3-sn-Phosphatidyl-
ethanolamine
Bovine brain PE Sigma-Aldrich
1,2-Diacyl-sn-glycero-3-
phospho-L-serine
Bovine brain PS Sigma-Aldrich
Cholesterol Synthetic Chol Sigma-Aldrich
L-α-phosphatidylinositol-
4,5-bisphosphate
Porcine brain PI(4,5)P2 Avanti Polar Lipids
1,2-dioleoyl-sn-glycero-3-
phospho-(1'-myo-inositol-
3',4',5'-trisphosphate)
Synthetic PIP3 Avanti Polar Lipids
Phorbol 12-myristate
13-acetate
Synthetic PMA Sigma-Aldrich
ATTO647N-1,2-dioleoyl-
sn-glycero-3-
phosphoethanolamine
Synthetic DOPE-647N Atto-Tec
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NL liposomes used for measurements of curvature sensitivity of Endophilin contained 38%
POPC, 25% PE, 20% PS, 2% PI(4,5)P2 and 15% Cholesterol (values given in molar
percentages). For PI(4,5)P2 titration experiments, POPC concentration was adjusted
accordingly to reach a final 100% molar content.
For vesiculation with ENTH, liposomes were made of Brain Extract (Sigma) with 2%
PI(4,5)P2.
5.2 Molecular Biology
All the constructs used in this thesis were cloned using Fragment Exchange (FX) cloning
[352]. A list of constructs can be found in table 5.3.
Chemocompetent cells were made using calcium chloride and standard protocols [353]. For
cloning, MACH1TM T1 competent cells (ThermoFischer Scientific) were used; for protein
expression, BL21(DE3) (ThermoFischer Scientific) were used.
For large-scale protein expression, either N-terminal His10-3C (p7xNH3 backbone), N-
terminal His10-SUMO (p7xNHS backbone) or N-terminal His10-GST-linker-3C (p7xNHGstG3
backbone) were used. GFP-fusion constructs used in NanoSight experiments were cloned
with an N-terminal His10-GFP-linker-3C or a C-terminal 3C-GFP-His10 tag (p7xNHmGfpG3
or p7xC3mGfpH backbones respectively). 3C denotes the Rhinovirus 3C protease cleavage
site.
Empty FX vectors were cloned based on p7xNH3 and p7xC3H by inserting SUMO, GST
or GFP using inFusionR© (ClonTech). A schematic of vectors used can be found in Fig. 5.1
Figure 5.1: Schematic drawing of vector backbones used.
10xHis: His-tag with 10 histidines, 3C: Rhinovirus 3C protease cleavage site, POI: pro-
tein of interest, SUMO: Small Ubiquitin-like Modifier tag, GST: glutathione S-transferase,
GSGS: Gly-Ser-Gly-Ser linker, EGFP: enhanced Green Fluorescent Protein
Table 5.3: Constructs used in this thesis
ID Short name Construct Tag Species Vector
acv385 Endo NBAR-sfGFP Endophilin A2(1-247) C-ter 3C-mGFP-His10 rat p7xC3mGfpH
acv413 FCHo2 BARX-sfGFP FCHo2(1-327)-Cys C-ter 3C-mGFP-His10 mouse p7xC3mGfpH
acv383 IRSp53 BAR-sfGFP IRSp53(1-250) C-ter 3C-mGFP-His10 human p7xC3mGfpH
acv450 Amphiphysin BAR-sfGFP Amphiphysin1(1-252) C-ter 3C-mGFP-His10 human p7xC3mGfpH
acv451 SNX9 PXBAR-sfGFP SNX9(204-595) N-ter His10-mGFP-linker-3C human p7xNHmGfpG3
acv389 AKT PH-sfGFP AKT(1-164) N-ter His10-mGFP-linker-3C human p7xNHmGfpG3
acv467 PLCd1 PH-sfGFP PLCd1(11-140) C-ter 3C-mGFP-His10 human p7xC3mGfpH
acv483 CYTH3 PH-sfGFP CYTH3(257-389) N-ter His10-mGFP-linker-3C human p7xNHmGfpG3
acv473 ING2 PHD-sfGFP ING2(201-280) N-ter His10-mGFP-linker-3C human p7xNHmGfpG3
acv474 ACF1 PHD-sfGFP ACF1(1131-1209) N-ter His10-mGFP-linker-3C human p7xNHmGfpG3
acv481 Dab2 PTB-sfGFP Dab2(33-191) C-ter 3C-mGFP-His10 human p7xC3mGfpH
acv482 IRS1 PTB-sfGFP IRS1(157-267) C-ter 3C-mGFP-His10 human p7xC3mGfpH
acv484 NCF4 PX-sfGFP NCF4(2-149) C-ter 3C-mGFP-His10 human p7xC3mGfpH
acv485 SGK3 PX-sfGFP SGK3(8-126) C-ter 3C-mGFP-His10 human p7xC3mGfpH
acv171 PICK1 PDZ-sfGFP PICK1(11-116) C-ter 3C-GFP-His10 human p7xC3GfpH
acv448 PKCδ C1-sfGFP PKCδ(220-290) N-ter His10-mGFP-linker-3C mouse p7xNHmGfpG3
acv445 PKCβ2 C1B-sfGFP PKCβ2(91-161) N-ter His10-mGFP-linker-3C human p7xNHmGfpG3
acv446 PKCβ2 C1BC2-sfGFP PKCβ2(91-289) N-ter His10-mGFP-linker-3C human p7xNHmGfpG3
acv468 PLCδ1 C2-sfGFP PLCδ1(621-756) N-ter His10-mGFP-linker-3C human p7xNHmGfpG3
Continued on next page
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acv469 cPLA2 C2-sfGFP cPLA2(17-140)C139A N-ter His10-mGFP-linker-3C human p7xNHmGfpG3
acv177 Syt1 C2-sfGFP Synaptotagmin1(97-422) C-ter 3C-GFP-His10 mouse p7xC3GfpH
acv466 PLCb1b C2-Gaq-sfGFP PLCb1b(677-1173) N-ter His10-mGFP-linker-3C human p7xNHmGfpG3
acv387 HRS FYVE-sfGFP HRS(149-230) N-ter His10-mGFP-linker-3C human p7xNHmGfpG3
acv471 EEA1 FYVE-sfGFP EEA1(1325-1411) N-ter His10-mGFP-linker-3C human p7xNHmGfpG3
acv472 WDFY3 FYVE-sfGFP WDFY3(3451-3516) N-ter His10-mGFP-linker-3C human p7xNHmGfpG3
acv388 FAK1 FERM-sfGFP FAK1(31-399) C-ter 3C-mGFP-His10 human p7xC3mGfpH
acv475 Talin1 FERM-sfGFP Talin1(1-401) C-ter 3C-mGFP-His10 human p7xC3mGfpH
acv476 KRIT1 FERM-sfGFP KRIT1(259-736) N-ter His10-mGFP-linker-3C human p7xNHmGfpG3
acv452 ANTH-sfGFP AP180(1-280) C-ter 3C-mGFP-His10 rat p7xC3mGfpH
acv418 ENTH-sfGFP Epsin1(1-164) C-ter 3C-mGFP-His10 human p7xC3mGfpH
acv479 MTR2 GRAM-sfGFP MTMR2(74-200) C-ter 3C-mGFP-His10 human p7xC3mGfpH
acv480 OXR1 GRAM-sfGFP OXR1(175-285) C-ter 3C-mGFP-His10 human p7xC3mGfpH
acv477 WIPI1-sfGFP WIPI1 C-ter 3C-mGFP-His10 human p7xC3mGfpH
acv478 WDR45B-sfGFP WDR45B C-ter 3C-mGFP-His10 human p7xC3mGfpH
acv453 AnnexinA4-sfGFP AnnexinA4 N-ter His10-mGFP-linker-3C human p7xNHmGfpG3
acv454 AnnexinA7-sfGFP AnnexinA7 N-ter His10-mGFP-linker-3C human p7xNHmGfpG3
acv398 MICALL1(668-863)-sfGFP MICALL1(668-863) C-ter 3C-GFP-His10 human p7xC3GfpH
acv486 MICALL1(676-803)-sfGFP MICALL1(676-803) C-ter 3C-mGFP-His10 human p7xC3mGfpH
acv487 MICALL1(690-803)-sfGFP MICALL1(690-803) C-ter 3C-mGFP-His10 human p7xC3mGfpH
Continued on next page
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acv520 NECAP1 Phear-sfGFP NECAP1(1-133) N-ter His10-mGFP-linker-3C human p7xNHmGfpG3
acv247 ENTH wt Epsin1(1-164) N-His10-SUMO cleaved human p7xNHS
acv281 ENTH L6W Epsin1(1-164)L6W N-His10-SUMO cleaved human p7xNHS
acv293 ADRA2A(299-374) ADRA2A(299-374) N-ter His10-GST-linker-3C human p7xNHGstG3
acv294 ADRA2A(299-339) ADRA2A(299-339)-Trp N-ter His10-GST-linker-3C human p7xNHGstG3
acv295 ADRB1(245-314) ADRB1(245-314)-Trp N-ter His10-GST-linker-3C mouse p7xNHGstG3
acv296 ADRB2(220-274) ADRB2(220-274)-Trp N-ter His10-GST-linker-3C human p7xNHGstG3
acv318 CIN85(327-412) CIN85(327-412)-Trp N-ter His10-GST-linker-3C human p7xNHGstG3
acv319 CIN85(390-428) CIN85(390-428)-Trp N-ter His10-GST-linker-3C human p7xNHGstG3
acv324 Alix Alix(748-770)-Trp N-ter His10-GST-linker-3C human p7xNHGstG3
acv374 SH3 EndophilinA1(294-352) N-ter His10-3C rat p7xNH3
103-65 Endo EndophilinA1 N-ter His6-3C rat pOPINF
acv400 EndophilinA1(294-352)-3C-Alix(748-770) N-ter His10-SUMO rat/human p7xNHS
acv494 Alix P9/12A Alix(748-770)P752/5A N-ter His10-GST-linker-3C human p7xNHGstG3
acv495 Alix P11A Alix(748-770)P754A N-ter His10-GST-linker-3C human p7xNHGstG3
acv493 Alix R14A Alix(748-770)R757A N-ter His10-GST-linker-3C human p7xNHGstG3
acv506 Alix P16A Alix(748-770)P759A N-ter His10-GST-linker-3C human p7xNHGstG3
acv505 Alix P17A Alix(748-770)P760A N-ter His10-GST-linker-3C human p7xNHGstG3
acv489 Alix P18/21A Alix(748-770)P761/4A N-ter His10-GST-linker-3C human p7xNHGstG3
acv496 Alix V19A Alix(748-770)V762A N-ter His10-GST-linker-3C human p7xNHGstG3
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acv490 Alix L20A Alix(748-770)L763A N-ter His10-GST-linker-3C human p7xNHGstG3
acv491 Alix R24A Alix(748-770)R767A N-ter His10-GST-linker-3C human p7xNHGstG3
acv516 Alix T7C Alix(748-770)T750A N-ter His10-GST-linker-3C human p7xNHGstG3
acv502 Alix P17C Alix(748-770)P759C N-ter His10-GST-linker-3C human p7xNHGstG3
acv499 Alix A25C Alix(748-770)A768C N-ter His10-GST-linker-3C human p7xNHGstG3
acv416 ADRA2A ADRA2A(293-339) N-ter His10-GST-linker-3C human p7xNHGstG3
acv527 SH3 E304C EndophilinA1(294-352)C294/5S-E304C N-ter His10-SUMO rat p7xNHS
acv533 ADRA2A D12C ADRA2A(293-339)D300C N-ter His10-GST-linker-3C human p7xNHGstG3
acv535 ADRA2A E24C ADRA2A(293-339)E312C N-ter His10-GST-linker-3C human p7xNHGstG3
95-1 EndophilinA2(309-366) N-ter GST-3C human pGex6P2
acv390 ADRA2A(293-339) wt ADRA2A(293-339) N-ter His10-SUMO human p7xNHS
acv391 ADRA2A(293-339)SSSS(8-11)DDDD ADRA2A(293-339)SSSS(296-9)DDDD N-ter His10-SUMO human p7xNHS
acv349 ADRA2A(293-374) wt ADRA2A(293-374) N-ter His10-SUMO human p7xNHS
acv350 ADRA2A(293-374)SSSS(8-11)DDDD ADRA2A(293-374)SSSS(296-9)DDDD N-ter His10-SUMO human p7xNHS
acv351 ADRA2A S72D ADRA2A(293-374)S360D N-ter His10-SUMO human p7xNHS
119-42 ADRA2A S43E ADRA2A(293-374)S331E N-ter His10-SUMO human p7xNHS
5.2.1 cDNA library generation
For cDNA library generation, RNA was extracted from HEK293T, HeLa and U2OS cell
pellets with the RNeasy Mini Kit part 1 (Qiagen) according to the kit instructions. cDNA
was synthesised from the extracted RNA with the SuperScript III kit (Invitrogen) using
5µg RNA as a template following the manufacturer's protocol. cDNA was synthesised both
with oligo-dT and random hexamer primers. To use as a template for PCR, cDNA from
all three cell lines and both primer sets were mixed and 1µl was used per PCR reaction.
5.2.2 Fragment Exchange (FX) Cloning
Fragment Exchange (FX) Cloning [352] is a restriction-ligation based method which uses
the type IIS restriction enzyme SapI that cleaves 3 bp away from its non-palindromic
recognition site. The 3 bp overhang were chosen by Geertsma et al. to be AGT (coding
for serine) at the 5' end of the insert and GCA (coding for alanine) at the 3' end. The
overhangs are different on each side of the insert to ensure directionality of the cloning.
The small, uncharged amino acids serine and alanine were chosen to limit the impact of
added amino acids on protein stability and activity.
During FX cloning, the insert is amplified by PCR. Both the insert and the vector are cut
by SapI in the same tube. This excises a cassette containing the negative selection marker
ccdB from the vector. After ligation and transformation into non-ccdB resistant bacterial
strain, vectors not containing the insert will cause ccdB-mediated bacterial death ensuring
close to 100% cloning efficiency.
Transfer from the donor vector into an expression vector happens through SapI digestion
and DNA ligation. Both reactions can be carried out simultaneously as in the expression
vectors, the SapI recognition sites are located in the excised cassette, so that after ligation
of the insert, no SapI sites remain. This ensures directionality of the reaction and increases
the yield.
5.2.3 Mutagenesis (HMM and AC)
Mutagenesis primers were designed with 8 bp upstream and 26 downstream of the muta-
tion to be introduced. PCR amplification was done with PhusionR© High-Fidelity DNA
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Polymerase (NEB) using GC buffer and touch-down PCR or with KOD Hot Start DNA
Polymerase (Novagen) with addition of betaine (Sigma) and standard protocols.
Template was digested using FastDigest DpnI (ThermoFischer Scientific). PCR products
were purified using NucleoSpinR© Gel and PCR Clean-up (Macherey-Nagel). To increase
the efficiency of annealing between both single-stranded ends, inFusionR© reaction was
performed.
5.3 Recombinant protein expression and purification
5.3.1 Recombinant protein expression in E. coli
Vectors containing the gene of interest under the control of the T7 promoter were trans-
formed in BL21(DE3) cells (ThermoFischer Scientific) and plated on TYE-agar containing
the corresponding antibiotic for selection. The next day, colonies were striked from the
plate and inoculated in 50ml 2xTY. After a few hours, 20ml preculture was added to 1 l
2xTY and cells were grown until OD600 reached 0.8-1. Protein expression was then in-
duced by addition of 160µM IPTG overnight at 18 ◦C. For small-scale protein expression,
the protocol was similar except that 1ml preculture was added to 50ml 2xTY.
5.3.2 Small-scale protein purification
50ml cultures were harvested by centrifugation 15min at 3000 g. Pellets were resuspended
in 3ml IMAC-L containing lysozyme and incubated for 10min at 4 ◦C. Cells were lysed
by sonication using a Microson Ultrasonic cell disruptor with a micro tip (Misonix in-
corporate). Unbroken cells and debris were pelleted 5min at 20000 g. The supernatant
was transferred in a fresh tube. After addition of DNaseI 1mM MgCl2 and 200µl 50%
TALON slurry, the cell lysate was incubated at 10min at 4 ◦C on a rolling shaker. Beads
were washed with 10ml IMAC-L, 1ml IEX-B (high-salt wash), 15ml IMAC-L. Protein was
eluted with 1ml IMAC-E.
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5.3.3 Large-scale protein purification
Large-scale protein purification was generally realised in three steps, an affinity capture
using His-tag, followed by an ion exchange column and finally size exclusion chromatogra-
phy.
Cultures were harvested by centrifugation 15min at 4200 g. Pellets were resuspended in
IMAC-L containing lysozyme and incubated for 10min at 4 ◦C. Cells were lysed by sonica-
tion using a Sonics VC 750. After addition of DNaseI and 1mM MgCl2, unbroken cells and
debris were pelleted 15min at 40000 g. The supernatant was loaded onto HisTrapTM HP
column (GE Healthcare). HisTrap column were washed with IMAC-L and IEX-B, then
protein was eluted with IMAC-E.
Depending on the pI of the protein, anion exchange (HiTrapTM Q) or cation exchange
(HiTrapTM SP) chromatography was used. Prior to loading on ion exchange column, NaCl
and imidazole were diluted out in IEX-A. An NaCl gradient ranging from 100mM to
500mM NaCl was run on ÅKTA Purifier 10 system.
For size exclusion chromatography, either SuperdexTM 75 or SuperdexTM 200 column (GE
Healthcare) was used depending on the size of the protein. The amount of protein de-
termined which size of column was used: 10/30, HiLoad 16/60 or HiLoad 26/60. Size
exclusion chromatography was run in GEF buffer or P-GEF for small peptides. Protein
was concentrated using Amicon Ultra centrifugal filter units (Merck Millipore) or, in the
case of small peptides in P-GEF buffer, by evaporation in a SpeedVac Vacuum concen-
trator (Eppendorf). Protein was then aliquoted, flash-frozen in liquid N2 and stored at
-80 ◦C
5.3.4 Protein labelling
For single-site maleimide labelling of a cysteine, endogeneous cysteines were mutated to ala-
nine or serine and a cysteine residue was mutated in, either at the N-terminus or in a loop.
Labelling reactions were set up as in the manufacturer's instruction with 50-100µM pro-
tein and ten-fold excess of Alexa488-maleimideR© (ThermoFischer Scientific) dissolved in
DMSO. TCEP (tris(2-carboxyethyl)phosphine) was added to reduce the cysteines. The la-
belling reaction was left for a few hours at room temperature or overnight at 4 ◦C. Excess
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of unreacted dye was removed by centrifugation filters. Degree of labelling was determined
based on A280 for protein concentration and A488 for dye concentration.
5.4 Biochemical assays
5.4.1 Liposome flotation
0.1mM liposomes were incubated with 1µM protein in 50µl final volume for 5 minutes then
mixed 1:1 with 80% HistodenzTM (Sigma) for a final 40 
% Histodenz concentration. This
was then layered with 50µl 30% Histodenz solution and 30µl NS buffer. After centrifu-
gation at 80000 rpm in TLA-100 (250000 g) for 20 minutes, 30µl fractions were collected
with gel loading pipet tips from the bottom of the tubes.
5.4.2 GST pull-down
Pellets from 10ml cultures of cells expressing GST-fusion proteins were resuspended in
0.75ml IMAC-L. Cells were lysed by sonication using a Microson Ultrasonic cell disruptor
with a micro tip (Misonix incorporate). DNaseI and 1mM MgCl2 were added, then unbro-
ken cells and debris were pelleted 5min at 20000 g. The supernatant was transferred in a
fresh tube. This centrifugation step was repeated to ensure clearance of the lysate. After
addition of 30µl Glutathione SepharoseR© 4B (GE Healthcare) 50% slurry, the lysate was
incubated 30min at 4 ◦C on an orbital shaker. Beads were washed six times with 1.4ml
PD buffer by centrifugation.
Lysate of cells expressing prey protein was prepared as above. 150µl lysate was incubated
with previously prepared beads loaded with GST-bait fusion protein for 10min at 4 ◦C on
an orbital shaker. The amount of beads used was previously normalised for the amount
of protein bound using SDS-PAGE. Beads were washed four times with 1.4ml PD buffer
by centrifugation. Beads were incubated with SB buffer at 95 ◦C and results analysed on
SDS-PAGE.
For pull-down with ADRA2A phosphomimetics mutants, His-SUMO-tagged peptides were
first enriched out of lysate from 2ml E. coli cultures overexpressing these constructs. The
cell lysate was incubated 5min with 60µl TALONR© slurry in IMAC-L buffer. The beads
were washed with IMAC-L and PD buffer and resuspended in IMAC-L. The peptides were
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cleaved off the beads with the SUMO protease His-SENPI and the resulting supernatant
was used as prey in pull-down experiments.
5.4.3 Isothermal Titration Calorimetry
ITC experiments were performed on an ITC200 calorimeter (GE-MicroCal) in GEF buffer
at 25◦C. For Alix-SH3 interaction, 45-80µM SH3 in the cell and 765µM Alix peptide in
the syringe were used. For measurements with ADRA2A, 1-1.2mM SH3 in the syringe
and 100-150µM ADRA2A peptide (wild-type and phosphomimetics) were used.
5.5 NanoSight measurements
NanoSight measurements were done on a NanoSight LM10 (Malvern) with a sCMOS cam-
era and a syringe pump. A 488 nm laser together with a 500 nm longpass filter was used for
green fluorescence. Fluorescent particles in the far-red range were detected using a 638 nm
laser and a 650 nm longpass filter.
To check the calibration, NIST (National Institute of Standards and Technology) traceable
calibration beads (3000 Series NanosphereR© Size Standards (ThermoFischer Scientific))
were diluted in water. Movies were recorded without pump flow and particles were tracked
using the company's software. Results used were FTLA (finite track length adjustment)
corrected according to the proprietary algorithm. For comparison with Dynamic Light
Scattering, a W130i DLS system (AvidNano) was used.
For measurements of curvature sensitivity, liposome solutions were diluted to reach final
2-8·108 particles/ml as recommended by the manufacturer. This corresponded to final
concentrations of 1µg/ml for unextruded or 800 nm extruded liposomes, 0.5µg/ml for
200 nm extruded liposomes and 0.125µg/ml for 50 nm extruded liposomes. Fluorescent
protein concentration was 1-5 nM to reduce fluorescent background of unbound protein.
Liposomes were diluted in NS buffer, then protein was added. After mixing, the sample
was loaded onto the NanoSight. Recordings were made under flow from the syringe pump
to reduce bleaching. 120-180 s long movies were recorded using appropriate camera settings
to maximise signal/background ratio. Particles were tracked using the company's software.
Raw, non-FTLA corrected data was used due to sample heterogeneity.
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Single particle tracking and data processing was carried out by the NanoSight NTA software
version 3.1 (Malvern). Binned data was analysed using GraphPad Prism version 6.0f for
Mac OS X, GraphPad Software, La Jolla California USA, www.graphpad.com. Box plots
were created using 25th to 75th percentile, with the middle line representing the median
and whiskers 10th to 90th percentiles.
5.6 NMR
5.6.1 Recombinant protein expression
For isotope-labelling for NMR, proteins were expressed in M9- supplemented with 1 g/l
15NH4Cl and 4 g/l 13C-glucose. Due to the lower yields in M9-, a protocol based on [354]
was used. The preculture was grown in 2xTY and 6 l of 2xTY were inoculated. When OD600
reached 0.6-0.8, cells were harvested by centrifugation 15min at 4200 g, washed twice by
resuspension/pelleting in M9- and finally resuspended in 1 l warm M9-. This culture was
incubated 40min at 37 ◦C for the cells to use up the remaining unlabelled nitrogen and
carbon sources before heavy isotopes were added. After 30min incubation during which
cells incorporate heavy isotope sources in their metabolism, protein expression was induced
by addition of 160µM IPTG overnight at 18 ◦C.
5.6.2 Protein labelling for Paramagnetic Relaxation Enhancement PRE
For 4-maleimido-TEMPO (2,2,6,6-tetramethyl-1-piperidinyloxy) (Sigma) labelling, con-
structs were designed to contain only one cysteine at a chosen position. Proteins were
kept reduced by a five-fold excess of TCEP. Labelling reactions were conducted with a ten-
fold excess of TEMPO for 4 hours at room temperature. Unreacted TEMPO was quenched
by an addition of a two-fold excess (over TEMPO) of DTT (dithiothreitol) for 30min at
room temperature. Free TEMPO was removed by dialysis against NMR buffer overnight
at 4 ◦C. After NMR spectra recording, TEMPO radical was quenched by incubation with
a five-fold excess of sodium ascorbate and NMR spectre were recorded again as a control.
112
5.6.3 Data collection (TR) and analysis (TR and AC)
Spectra were collected on 600 and 800 MHz Bruker Advance III (Bruker) spectrometers
equipped with a triple-resonance inverse cryogenic probe head at 10 ◦C sample temper-
ature. Backbone resonance assignments were performed using standard triple-resonance
experiments (HNCACB, CBCA(CO)NH, HNCO and HN(CA)CO), acquired using unmod-
ified Bruker pulse programs. Chemical shift perturbations were recorded by comparing fast
HSQC spectra [355] obtained with typically 1024 and 256 data points in t2 and t1, cover-
ing spectral widths of 14.0 and 40 ppm, respectively. The digital resolution of processed
data was 1.5 and 4.3 Hz/point in f2 and f1. Spectra were processed with TopSpin ver-
sion 3 (Bruker) and analysed with Sparky version 3.115 [Goddard T. D. & Kneller D. G.,
SPARKY 3, University of California, San Francisco].
For titration experiments, occupancy on the isotopically labelled binding partner was cal-
culated using an in-house spreadsheet for solving saturation binding equations. Concentra-
tions were chosen so that in the fully saturated complex, occupancy of the labelled material
was >95%. For the intermediate concentration point, concentrations were chosen to reach
an occupancy of 25%.
CSP were quantified as CSP =| ∆δ1H | +1/5 | ∆δ15N |, where | ∆δ | is the absolute
change in chemical shift. Solvent accessibility of residues in Endophilin SH3 structure (pdb
2KNB) was calculated using NACCESS [S. Hubbard and J. Thornton 1992-6]. Modelling
was performed using HADDOCK [343, 344]. A threshold of >40% relative solvent ac-
cessibility was used to define active interaction restraints (AIR) in HADDOCK modelling.
Passive residues (residues which have lower CSP and/or are in proximity of active residues)
were assigned automatically.
Docking calculations were performed by submission to the HADDOCK2.2 web server [344].
The docking simulations were performed with default server parameters throughout, except
that non-polar hydrogen atoms were not removed and the peptides were defined to be fully
flexible along the entire length. The default option to randomly exclude a proportion
of active restraints was disabled. The starting model for Endophilin SH3 was taken from
Protein Data Bank submission 2KNB [229], with the Ubl domain removed. Starting models
for Alix and ADRA2A peptides were constructed with PyMol software [PyMol Molecular
Graphics System, version 1.8.4, Schrödinger, LLC.], setting all backbone torsion angles
initially set to conform to elements of regular secondary structure (φ, ψ = -78 ◦, 149 ◦
113
for polyproline-II helix, -57 ◦, -47 ◦ for α-helix; -139 ◦, -135 ◦ for β-strand). Models were
subjected to docking, semi-flexible refinement followed by refinement with explicit water
solvation, with convergence statistics generated for 200 individual models.
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